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Abstract 
Stroke is often a severe and debilitating event that requires ongoing rehabilitation. The 
Community Stroke Rehabilitation Teams (CSRT) offer home-based stroke rehabilitation to 
individuals for whom further therapy is unavailable or inaccessible. The objective of this 
study was to evaluate the cost-effectiveness of the CSRT program compared with a ‘No 
Therapy’ cohort. Data were collected on CSRT clients from January 2012 to February 2013. 
Comparator data were derived from a study of stroke survivors with limited access to 
rehabilitation. Literature derived values were used to inform a long-term projection. Using 
Markov modelling, we projected the model for 35 years. One-way, two-way, and 
Probabilistic Sensitivity Analyses were performed. Results demonstrate that the CSRT has a 
Net Monetary Benefit of $43,115 over No Therapy, and is both less costly and more 
effective. The CSRT model of care should be considered when evaluating potential stroke 
rehabilitation delivery methods. 
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Preface  
The following thesis is presented in integrated article format. Although care has been taken 
to ensure clarity and concision, some repetition is inevitable.  
 
  
  
1 Introduction 
This chapter will provide a brief introduction to the topic of stroke. It will also provide a 
background to the efficacy of post stroke rehabilitation, the structure of stroke care in Ontario, 
and an introduction to the Community Stroke Rehabilitation Teams.  
 Stroke 
Stroke, also known as a cerebrovascular accident or ‘brain attack’, occurs when the brain is 
deprived of blood supply (ischemic stroke) or when the blood-brain barrier is breached via 
vascular rupture (hemorrhagic stroke).1 Stroke is a potentially severe and debilitating event that 
affects up to 50, 000 Canadians each year.2 With better acute care, the number of individuals 
surviving a stroke is rising, with nearly 85% surviving their initial stroke, often with resulting 
impairments.3 As such, stroke is the second leading cause of long-term disability in North 
America .2 
Stroke effects can range in severity, with resulting impairments varying from minor issues that 
may resolve within a short time, to severe and long lasting disabilities. The effects of stroke 
include physical disabilities, depression and anxiety, problems with language and 
communication, perceptual deficiencies, and declines in cognitive abilities, memory, and 
executive functioning.1 Many of these outcomes improve substantially if the affected individual 
receives specialized rehabilitation. This rehabilitation may begin in the acute care setting, and 
often continues well into the post-acute and chronic phase. Specialized stroke rehabilitation is 
often an integral component of stroke recovery, and has been shown to result in improved long-
term outcomes for the stroke survivor. 4    
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 Stroke Rehabilitation  
The ultimate goal of stroke rehabilitation is to ensure that stroke survivors are able to reach their 
maximum recovery potential from physical, psychosocial and cognitive impairments in order for 
them to regain as much of their prior function as possible.5 Rehabilitation often aims to improve 
function in activities of daily living (ADL), facilitate return to work in younger stroke survivors 
and those still employed, and improve physical independence, psychosocial, and cognitive 
wellbeing.5 Stroke rehabilitation services often have an additional focus on the improvement of 
social wellbeing, emphasizing the importance of recreation and social activities in a person’s 
overall quality of life.   
Both the efficacy and effectiveness of stroke rehabilitation have been examined in hundreds of 
studies. The Evidence Based Review of Stroke Rehabilitation (EBRSR)4 cites over 1300 
Randomized Controlled Trials (RCT) that evaluated therapies for deficits caused by stroke. Many 
of these studies focused on the efficacy of treatments for upper and lower limb physical 
rehabilitation, cognitive and language therapies, treatments for perceptual impairments, 
dysphagia and nutritional interventions, and the value of treatment strategies aimed at community 
reintegration. Thousands more observational studies exist, adding to the overwhelming evidence 
in favour of rehabilitation therapies following a stroke. These studies examined the effectiveness 
of treatments throughout the stroke recovery process, including during the post-acute and chronic 
stage, suggesting that rehabilitation should be an ongoing process. 
1.2.1 Acute Stage 
Five published meta-analyses support the efficacy of specialized stroke rehabilitation services.  
All report a reduction in mortality for individuals treated by specialized stroke rehabilitation 
services compared with control groups who typically received traditional care.6-10 Positive effects 
have been noted for reducing mortality (OR = 0.79, 95% CI 0.73-0.86), poor functional outcomes 
(OR = 0.87; 0.80 -0.95),10 combined death or dependency (OR = 0.82; 0.73-0.92),9 and combined 
death or institutional care (OR = 0.82;  0.73- 0.92).9 One meta-analysis8 also found an increased 
odds of a stroke survivor returning to their own home following discharge from a specialized 
stroke program (OR = 1.42; 1.05 - 1.92).  It has been widely demonstrated that successful stroke 
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rehabilitation can have an enormous influence on both the improvement in function and quality 
of life for not only the stroke survivor, but for family members and caregivers as well. 
1.2.2 Post-acute stage 
Other studies have examined the impact of post-acute outpatient stroke rehabilitation. These 
studies are often more focused on therapies aimed at improving specific deficits. Although results 
have been somewhat conflicting, several studies have demonstrated effects of outpatient 
rehabilitation including increased independence in activities of daily living,11-13 improvement in 
social outcomes,14  lower hospital readmission rates,15 improvement in depression and anxiety 
symptoms,16,17 fewer medical complications,16 and greater functional improvement17 compared 
with control groups receiving no further therapy.  
1.2.3 Chronic stage 
Studies of recovery in the chronic phase of stroke are much fewer than the acute and post-acute 
stages. When evaluating outpatient rehabilitation in the chronic stage of stroke recovery (>6 
months post stroke), significant improvements were noted in activities of daily living,11,12 
mobility,18,19 and functional independence 20 compared with controls. However, in the majority of 
these studies, gains were no longer statistically significant between treatment and control groups 
at long-term follow up assessments (i.e. >6 months post baseline).  
 
 Stroke Care in Ontario, Canada 
There are several treatment pathways a patient may take following acute stroke care. Figure 1.1 
provides a visual representation of conventional patient flow through the stroke treatment system. 
The traditional tactic in stroke rehabilitation is immediate stroke treatment in an acute inpatient 
setting, often followed by transfer to a specialized inpatient stroke rehabilitation unit for 
individuals who would benefit from additional inpatient hospital treatment. From hospital, 
individuals are often discharged home when appropriate, or to Long Term Care in the case of 
severe impairments and lack of necessary caregiver support.  Many individuals discharged home 
would benefit from additional outpatient hospital-based rehabilitation services. However, these 
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comprehensive outpatient services are often not available and, when present, tend to be available 
only in larger city centres and are, therefore, inaccessible to many. These individuals are often 
left with no further rehabilitation services.  
 
Figure 1.1: Possible routes of patient flow through the Ontario stroke system 
Stroke rehabilitation services traditionally consist of multidisciplinary teams who provide 
comprehensive support to their patients. These teams are often made up of the following 
specialized services: 
- Physiotherapy: facilitate the improvement of mobility and physical activity21 
- Occupational therapy: identification, engagement, and improved function in activities 
of daily living22 
- Speech-language therapy: the treatment of language, speech, voice  and 
communication disorders23 
- Therapeutic Recreational therapy: the incorporation of recreation and leisure as 
essential components to improved quality of life24 
- Registered Nurse: provision of basic medical support and health education  
Although these rehabilitation services are currently available to most individuals at the inpatient 
level, and many stroke survivors go on to attend outpatient rehabilitation clinics, there are many 
Acute Stroke 
Care
Outpatient 
Rehabilitation
Home-Based 
Rehabilitation
Inpatient 
Rehabilitation
Home-Based 
Rehabilitation
Outpatient 
Rehabilitation
LTC No Service
LTC No Service
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who have no services available to them or are unable to access these services. In-home, 
community-based rehabilitation aims to fill this extensive and concerning gap.  
Current Canadian stroke rehabilitation guidelines exist to ensure that stroke survivors receive the 
best evidence based stroke rehabilitation care possible. The Canadian Best Practice 
Recommendations for Stroke Care are widely practiced and encompass guidelines specific to 
acute, inpatient, outpatient, and community-based rehabilitation.25 The guidelines are updated 
periodically with recommendations supported by the literature and past studies of high 
methodological quality. They embrace rehabilitation as a multidimensional approach, 
incorporating medical, social, emotional, and vocational resources to optimize recovery.26 It has 
been postulated that consistent access to this organized, multifaceted approach to stroke 
rehabilitation could save the Canadian health care system $8 billion over the next 20 years 
through both stroke prevention and reduction in disability.27 
The Canadian Best Practice Guidelines for Stroke Care (2013), Outpatient and Community-
Based Rehabilitation, state that individuals with ongoing needs “should continue to have access 
to specialized stroke services after leaving hospital” and that “[o]utpatient and/or community-
based rehabilitation services should be available and provided by a specialized interprofessional 
team, when needed by patients […]”.25 The guidelines further state that this rehabilitation should 
be provided in the most appropriate setting, including the person’s own home.28  
1.3.1 The South West Local Health Integrated Network (LHIN) 
The South West LHIN, located in the province of Ontario, Canada, covers a large geographic 
area of approximately 21,639 square kilometers and encompasses Middlesex, Oxford, Eglin, 
Huron, Perth, Grey, Bruce, and a portion of Norfolk counties (Figure 1.2). It is home to nearly 1 
million residents, including a large rural population. Over 23% of individuals living in this LHIN 
who experienced a stroke in 2013 are considered to be rural residents.29  
Stroke services in the South West LHIN are currently centered in 2 dedicated acute stroke 
hospitals. Hospital-based outpatient rehabilitation services are currently available at 14 sites. 
Despite this, over 35% of stroke patients, including 40% of acute patients, are discharged home 
with no further rehabilitation services. This rate may be as high as >50% in more rural areas.30 
Research has shown that less than 10% of stroke patients will make a full recovery, with the 
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remaining requiring ongoing rehabilitation.2 Furthermore, 25% of stroke sufferers are left with 
minor disability, and 40% with major disability, requiring therapy.2 This demonstrates a large 
service gap in access to rehabilitation services in individuals who would benefit from further 
rehab.29 
 
Figure 1.2: The South West Local Health Integrated Netork31 
 
 The Community Stroke Rehabilitation Teams 
The Community Stroke Rehabilitation Teams (CSRT) were founded in 2009 and service the 
eight counties of the South West LHIN. These teams receive annual funding provided by the 
South West LHIN. They aim to provide Canadian Best Practice Recommendations for Stroke 
Rehabilitation25 to adult stroke survivors living in their homes, and who are otherwise unable to 
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access traditional outpatient rehabilitation services due to mobility, transportation, or 
geographical limitations.  
Due to the large geographic area of the Southwest LHIN, the CSRT program comprises three 
individual teams centred in three cities across the LHIN. The Thames Valley team is located in 
London and serves Middlesex, Elgin, Norfolk, and Oxford counties; the Huron Perth team is 
located in Seaforth and provides therapy to clients in Huron and Perth counties, and the third 
team is centred in Owen Sound and serves Grey and Bruce counties.  
The CSRTs deliver an interdisciplinary approach to stroke rehabilitation by providing service 
individualized to each client. This may involve physical rehabilitation, social and emotional 
support, education, system navigation, and caregiver support.32 Provision of these services may 
involve the support of a registered nurse, social worker, occupational therapist, physiotherapist, 
speech-language pathologist, therapeutic recreation therapist, or rehabilitation therapist. These 
therapists work together to provide a comprehensive program of rehabilitation to each individual, 
and provide this therapy directly in a person’s home and around their community. It has been 
suggested that comprehensive and intensive rehabilitation is more effective than less intense 
programs of therapy.5 The CSRTs are able to provide relatively intense rehabilitation, with type 
and frequency of visits individualized to each client, in a home setting. 
Although there is currently a lack of published data on the cost of this particular program relative 
to hospital-based outpatient services, or no rehabilitation service, anecdotal evidence from the 
CSRTs indicates that clients served by the CSRTs may access fewer health care resources over 
time. These include readmission to hospital, emergency room visits, general physician visits, and 
other social services. There may also be decreased costs to the patient as a result of fewer travel 
costs, private therapies accessed, and loss of employment wages, particularly accrued by family 
members who often must provide transportation to the outpatient facility. It is hypothesized that 
the upfront cost of the CSRTs to the health care system is greatly offset over time by cost savings 
in these other areas.  
Based on the lack of published evidence pertaining to the economic value of the CSRTs, the 
current study aimed to assess the cost-effectiveness of this particular program. The next sections 
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provide an evaluation of the existing literature on specialized stroke rehabilitation, in particular 
home-based stroke rehabilitation.  
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2 Review of the Literature 
Home-based stroke rehabilitation programs have been the subject of a number of studies around 
the world.  This chapter provides a review of the evidence pertaining to the effectiveness of 
home-based rehabilitation. For the purposes of this review, studies of Early Supported Discharge 
(ESD) programs have generally not been included as ESD is not the mandate of the Community 
Stroke Rehabilitation Teams. Clients served by the CSRTs come from a range of referral sources, 
while Early Supported Discharge programs often act exclusively as a substitute for inpatient 
rehabilitation, treating patients in the acute phase of their stroke. The economic burden of stroke 
in Canada, and current evidence surrounding the cost-effectiveness of home-based rehabilitation, 
also will be reviewed.  
 
 Home-Based Stroke Rehabilitation  
In the majority of health care systems, stroke care is initially offered in the inpatient hospital 
setting. Many individuals, upon discharge, are able to receive ongoing rehabilitation in the 
hospital-based outpatient setting. However, these outpatient services are not available to all 
stroke survivors with ongoing needs. 
In recent years, the idea of home-based rehabilitation has begun to garner support as a practical 
option for delivery of specialized stroke therapy services following discharge from hospital. This 
type of service is often directed at individuals who have ongoing rehabilitation needs and for 
whom traditional hospital-based outpatient rehabilitation services are not available, not accessible 
(i.e. transportation barriers), or simply as an alternative to traditional facility-based outpatient 
services.   
Home-based stroke rehabilitation teams, as the name suggests, provide services directly in a 
person’s home and, in some cases, in their community. These teams most often limit their therapy 
setting to a person’s household environment, however, some of these teams may also offer 
opportunities to go into the community for therapy sessions. This may include navigating the 
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grocery store with their therapist, practicing communication skills in the local coffee shop, or 
climbing and descending the stairs of the local post office.  
These home-based programs often structure their highly individualized therapies around a 
person’s specific goals, and focus on improving activities of daily living to optimize function. 
This approach may be quite effective as a person’s home is often the most appropriate and 
effective setting for this recovery to take place.  In this way, stroke patients are better able to cope 
with, and overcome, barriers specific to their home and community environments. This client-
centred approach to stroke rehabilitation can be effective and is often valued highly by the stroke 
survivor.  
Home-based stroke rehabilitation programs differ greatly in their professional make up, client 
inclusion criteria, and organization of services. They may also vary in the intensity of therapies 
and length of services offered.  
Although it is well recognized that home-based stroke teams vary widely in professional makeup, 
studies examining the effectiveness of these teams do not often describe this in great detail. These 
teams most often consist of some combination of team coordinator, physiotherapist, occupational 
therapist, speech-language pathologist, social worker, nurse, and recreational therapist. In the 
majority of cases, however, teams consist of a physiotherapist and occupational therapist as their 
core component. In a systematic review by Winkel et al.,33 all eight of the included studies 
involved these two disciplines as a part of their multidisciplinary team structure.33 Five of the 
examined studies also included a registered nurse as a part of their offered services, and a speech-
language therapist was included in four teams. In two studies, social workers were permanent 
members of the rehabilitation team, but were included only on a consultation basis in several 
other programs. A number of studies also included the direct involvement of a physician.  Upon 
further examination of the literature on in-home stroke rehabilitation teams, additional health care 
professionals such as psychologists,34 dieticians,34 therapy aides , and physical medicine 
physicians34 also have been included as members of these interdisciplinary teams. Additionally, 
some in-home rehabilitation teams are offered in combination with personal support worker and 
other home care services, further influencing their functionality and impact.26 
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The majority of home-based stroke rehabilitation programs described in the literature have wide 
eligibility criteria. Most programs offer therapy to any adult stroke survivor who has 
rehabilitation needs as a result of their stroke and is able to participate in therapy.26,34-38 Other 
programs limit services to only those with acute stroke.39,40 Some home-based stroke programs 
may offer services in the form of Early Supported Discharge (ESD) from hospital, which allows 
patients to return to their own homes with support days and even weeks sooner than may 
otherwise would have occurred in the absences of such a program. 33,40-42  
The intensity of therapy provided to clients served by home-based stroke rehabilitation teams 
may also varies widely. In many cases, the amount and duration of therapy provided is highly 
individualized to each client.26,37,40-42 Other structures consist of a predetermined maximum of 
anywhere from two38 to five34 sessions per week, and include a maximum duration of services. 
Programs may also incorporate a period of self-management in which stroke survivors are able to 
practice the skills they have acquired during the period of rehabilitation.38  
 
 Current Evidence Supporting Home-Based Rehabilitation  
Although in-home rehabilitation provides a unique opportunity for recovery in the most useful 
and practical environment, evidence of the effectiveness of home-based stroke rehabilitation 
programs is still incomplete.  Many of the currently available Randomized Controlled Trials and 
observational studies compare this type of care to hospital-based outpatient rehabilitation, with 
the majority of studies conducted in the United Kingdom, Australia, and Scandinavia.  
Furthermore, the majority of this literature compares this type of program with an Early 
Supported Discharge (ESD) approach to inpatient rehabilitation. Both inpatient rehabilitation and 
traditional outpatient services are efficacious in improving patient outcomes post stroke.4  
Many of the studies comparing home-based vs. hospital-based rehabilitation test the null 
hypothesis that one treatment approach is ‘non inferior’ to the other. In other words, they aim to 
demonstrate that home-based rehabilitation is as effective as traditional outpatient-based services. 
It has been widely demonstrated that outpatient therapies are effective at improving a wide range 
of patient outcomes post stroke.4  A significant difference between the treatment groups, although 
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important to consider, should be interpreted with caution as clinically meaningful differences 
specific to each outcome measured may differ from statistical significance. Likewise, clinically 
meaningful changes may be observed in one treatment group and not another without being 
statistically different.43 
2.2.1 Evaluated Outcomes for Home-Based Rehabilitation 
2.2.1.1 Functional Outcomes 
The majority of studies of the efficacy of in-home rehabilitation post stroke have looked at areas 
of disability, physical function, and improvement in activities of daily living (ADL) as primary 
outcomes.  ADLs include basic activities such as grooming, toileting, and other forms of self-
care, household and other day-to-day tasks, as well as leisure activities. These outcomes are 
important measures of the disability level of an individual.  
A number of outcome measures are used to quantify disability following a stroke. The most 
commonly used internationally are the Barthel Index (BI), the modified Rankin Scale (mRS), and 
the Functional Independence Measure (FIM), although many more exist.44 These measures have 
been the subjects of numerous validation studies, and cut-off scores for various disability levels 
are well established.45-49 Increasingly, the Stroke Impact Scale (SIS)50 is being used as a measure 
of function following stroke, particularly in North America. The short form of this measure, the 
SIS-16, is used to create a physical dimension score. This measure has been validated in 
comparison to both the mRS and the Barthel Index and has been shown to be able to distinguish 
among disability levels of both measures.51,52 A person’s level of disability in the months 
following stroke has been shown to have an impact on their continued recovery, independence in 
daily activities, and overall health related quality of life.53-56 
Disability and Activities of Daily Living 
Significant improvements in ADLs in home-based intervention groups have been observed in the 
majority of studies examining this outcome; however, in most cases the intervention group was 
compared with a control group receiving outpatient rehabilitation and researchers were not able 
to observe differences between the two cohorts.34-37,39,40,57 In one study, although there were no 
significant differences between study groups, an earlier improvement was noted in the home 
intervention group.58 Some studies have been able to demonstrate a significant improvement in 
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favour of home-based treatment groups when compared with hospital-based controls. Studies by 
both Gladman et al.59 and Chaiyawat and Kulkantrakorn17 showed greater improvement in 
independence in activities of daily living (Barthel Index, p<0.05 at six month follow up;  Barthel 
Index, p=0.03 at two years).17,59  In a one group, pre-post study design by Sirbu et al.,38 study 
investigators were also able to observe significant improvement in activities of daily living 
(Barthel Index, p=0.02).38 There is a consensus that in-home rehabilitation is successful in 
increasing independence in activities of daily living.  
Motor Skills 
Improvement in motor function is also commonly assessed in the context of in-home 
rehabilitation. As is the case with improvements in ADLs, in-home rehabilitation programs are 
able to demonstrate significant improvements over time. However, when between group 
comparisons are examined, no superiority of home-based rehabilitation was observed over 
hospital-based therapy. This was the case in studies of manual dexterity,39,40 assessments of 
motor processing skill,34 motor impairment as measured by the Motricity Index and the Motor 
Assessment Scale,35,39 and upper extremity motor control and dexterity on the Frenchay Arm 
Test.39 Bjorkdahl et al.58 were also not able to observe a between-group difference in motor 
function improvement, although an earlier improvement was noted in the in-home rehabilitation 
intervention group.58 Conversely, in a one group pre-post-test, Sirbu38 was not able to observe 
any significant improvement in motor functioning on the Motricity Index between time points.38 
Once again, motor function appears to improve in individuals receiving in-home therapy services 
post stroke.  
Mobility 
Along with motor function and independence in ADLs, mobility is typically assessed as a 
measure of overall physical functioning in the stroke patient. Once again, home-based therapy 
has repeatedly been demonstrated to show significant improvements in mobility, although it has 
not been shown to be superior to control participants receiving hospital-based services in 
measures of: walking capacity,40 a timed test of standing to walking,34 the 30 minute walk test,58 
tests of 10 minute walking speed,39 and overall mobility.57 A group of researchers using a one 
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group pretest-post-test design demonstrated a significant improvement in mobility on the Berg 
Balance Scale (p=0.05).38  
Overall Functional Recovery  
Overall function is also often assessed when examining the effectiveness of in-home 
rehabilitation. Although significant improvements are typically observed in overall health, daily 
activities, mobility, and social functioning, they have not been observed to be superior to 
improvements seen in individuals accessing traditional outpatient or community services. This 
has been observed in results from the Functional Independence Measure,57  Nottingham Health 
Profile,59 and National Institute of Health Stroke Scale.58 Furthermore, when compared with 
individuals receiving limited community rehabilitation services, a recent Canadian study by 
Markle-Reid et al.26 was not able to observe any superiority of the home-based intervention 
program on this particular outcome. Additionally, two studies have shown dominance of hospital-
based rehabilitation on improvements in overall measures of function as was observed in a study 
of young stroke survivors by Bjorkdahl et al.58 Superiority of hospital over home-based 
rehabilitation in functional improvement was also observed by Crotty et al.,34 although authors 
acknowledge a substantial risk of bias with this result.34 
Finally, authors of two studies have compared in-home rehabilitation treatment groups with 
controls in the area of overall activity level. Ljungberg et al.57 observed significant improvements 
in activity level, information level, and participation in the planning of program activities (all 
p<0.05) in home-based treatment groups.57 Conversely, Anderson et al.42 were not able to 
observe such an effect when examining the impact of in-home rehabilitation on activity level in 
the context of early supported discharge.42  
Overall, in-home rehabilitation has been widely demonstrated to be effective at improving 
physical outcomes of stroke patients including improving independence in activities of daily 
living, motor function, and mobility. There is conflicting evidence that home-based rehabilitation 
is able to improve an individual’s overall function when compared with a hospital-based 
outpatient population.   
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2.2.1.2 Psychosocial Well-being  
The psychosocial wellbeing of stroke survivors is also often examined in studies assessing in-
home rehabilitation programs. These studies typically look at the presence and severity of anxiety 
and depressive symptoms, but may also examine patient satisfaction, coping skills, and return to 
normal social functioning.  In the majority of studies, as with physical and functional outcomes, 
improvement in the psychosocial domain was not found to have improved to a greater degree in a 
sample receiving in-home rehabilitation when compared with outpatient therapy services. 
However, in most cases, statistically significant improvements were observed in both groups on 
measures such as the Hospital Anxiety and Depression Scale,35,36,39 and the Geriatric Depression 
Scale.34 One study looking at in-home rehabilitation compared with a control group receiving 
limited services was not able to detect any difference in depression and anxiety symptoms.26 
Conversely, Chaiyawat and Kulkantrakorn17 was the only study to detect a significant 
improvement in a treatment group compared with a control group who had limited access to post-
stroke rehabilitation services (p<0.01).17 This suggests that home-based therapy is not inferior to 
hospital-based treatment in improving symptoms of depression and anxiety in stroke survivors, 
and may be superior to a no therapy alternative.  
An improvement in coping skills was examined in one study40 in the context of Early Supported 
Discharge and was found not to be significantly better in the treatment group versus controls 
discharged early from inpatient rehabilitation. Reintegration to normal living was also examined 
by one group. There were no significant improvement in treatment subjects compared with 
controls who did not receive rehabilitation.26 
In an RCT by Lincoln et al.,37 participants receiving services from a community stroke 
rehabilitation program were significantly more satisfied with the emotional support they received 
from the team compared with controls receiving services outside the home setting as measured by 
a study assessment measuring emotional satisfaction with services (p=0.02). Similar results have 
been noted in a number of other studies.41,60  
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2.2.1.3 Caregiver Burden 
Many home-based rehabilitation programs also provide support to family members and friends of 
stroke survivors, aiming to improve caregiver outcomes following stroke. These most often focus 
on psychosocial wellbeing, as well as overall health status.  
In an RCT by Lincoln et al.,37 caregivers of persons who suffered a stroke who received services 
from home-based rehabilitation programs reported considerably less burden (p<0.04), and 
reported more knowledge of stroke (p=0.03) than the hospital outpatient-based control group. 
Furthermore, these caregivers showed greater improvement on the Caregiver Strain Index 
(p=0.03) and reported a greater overall satisfaction with services (p=0.01). Although Lincoln et 
al.37 were able to demonstrate less caregiver strain in treatment groups at a six month follow up, a 
study by Crotty et al.34 did not show a similar effect. However, a significant result was observed 
in this study upon hospital discharge (p=0.047). Several other investigators have not been able to 
show any improvement in treatment groups over controls when examining caregiver 
outcomes.34,35,37,39,42  
Converse to outcomes of physical and psychosocial recovery in stroke patients, studies that 
examine improvements in caregiver outcomes have been able to show more benefit in favour of 
home-based treatment groups when compared with standard rehabilitation controls.  
2.2.1.4 General Morbidity and Mortality  
A number of common outcome measures exist that assess overall general physical and cognitive 
wellbeing. Furthermore, general health outcomes may also be used to assess overall health status.  
As previously observed with other outcome domains, significant improvements in overall health 
status are generally are not observed when comparing home-based rehabilitation services with 
standard outpatient care or early supported discharge. However, in the majority of cases both 
intervention and control groups show significant improvement over time on measures such as the 
General Health Questionnaire,37 EuroQol,36,37 and the Short Form Health Survey (SF-36).34,42 
Markle-Reid et al.,26 whose study compared in-home rehabilitation with limited post stroke 
therapy services, was able to demonstrated an improvement in the treatment group on five out of 
eight subscales on the SF-36.26 Although none of these comparisons reached statistical 
significance, both the physical and social subscales improved by a clinically meaningful amount.  
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Improvements in cognitive functioning are also often assessed.  As before, very few studies have 
demonstrated any superiority of home-based rehabilitation when compared with traditional 
rehabilitation services, although statistically significant improvements in these outcomes are 
observed in both groups, particularly on the Mini Mental State Examination.34,35,40,42 One study 
was not able to find superiority of at home rehabilitation in improving cognitive outcomes when 
compared to a no or limited therapy group.17 Furthermore, one study found no improvement in 
cognition in either the intervention or the control group on the Barrow Neurological Institute 
Screen for Higher Cerebral Functions.58 Conversely, a Randomized Controlled Trial by 
Ljungberg et al.57 did show significant improvement in several cognitive domains when 
compared to a control group. Between admission and study end, significant improvements were 
observed in expression (p<0.01) and problem solving (p<0.05). Furthermore, between admission 
and 4 week follow up, significant improvements were seen in comprehension (p<0.05), problem 
solving (p<0.01), and memory (p<0.05) domains on tests of neurological status and cognitive 
functioning.57 
Rates of death, institutionalization, hospital readmissions, and recurrent stroke have also been 
reported by few studies. One study comparing home and hospital rehabilitation did not detect any 
significant difference between the two groups on death rates and rates of institutionalization.59 
Furthermore, when compared with no or limited therapy, investigators did not detect any 
significant difference in the rates of recurrent strokes or hospital readmissions in their study 
participants.26  
2.2.1.5 Other Benefits 
A number of additional benefits of community and in-home stroke rehabilitation have been cited 
throughout the literature. These include, but are not limited to, providing a means of early 
supported discharge from inpatient hospital care, and greater patient and caregiver satisfaction 
with the program.  
The potential for Early Supported Discharge (ESD), although not discussed in this review, may 
also lead to cost savings through shorter hospital stays, as well as an early return to independence 
and a higher rate of well-adjusted living as measured by the Return to Normal Living Index.61 
Both Anderson et al.42 and Widen Holmqvist et al.40 compared home-based rehabilitation with 
routine, inpatient hospital-based therapy. Both studies observed a significant reduction in the 
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length of hospital stay in individuals discharged to in-home rehabilitation (Holmqvist et al.: 14 
vs. 29 days, p=0.0008).40,42  
It has also been reported that home-based rehabilitation can result in increased satisfaction in 
services for both patients and caregivers. A study conducted in Sweden by Von Koch, Wohlin-
Wotricht, and Widen-Holmqvist41 found that home-based therapy enabled patients and family to 
be involved in the planning process, and allowed for greater opportunity to set relevant and 
achievable rehabilitation goals through a greater understanding of the needs and context of the 
programs clients. This resulted in greater client and caregiver satisfaction. Ljungberg et al.57 cited 
that further benefits include a person’s opportunity to make their own choices, which may further 
lead to the potential to be more active and motivated.57  
2.2.1.6 Meta-Analysis  
Meta-analysis of outcomes related to in-home rehabilitation is a challenge due to heterogeneity 
between programs, therapy intensities, structures, services provided, and outcomes examined. In 
a meta-analysis of Randomized Controlled Trials comparing home-based and centre-based stroke 
rehabilitation facilities, home-based services were associated with greater client satisfaction, 
reduced caregiver strain, lower readmission rates, and increased function and ADLs in a broad 
summary of results.33 Pooled analysis of functional outcome as measured by the Barthel Index 
also demonstrated a significant increase in functional independence compared with control 
groups by 6-8 weeks post intervention (p=0.03). Analysis of six month follow up scores also 
revealed significant improvements compared with controls on this measure (p=0.04).  This 
review noted that home-based rehabilitation may be superior from a patient outcome perspective, 
in part because individuals have the opportunity to immediately transfer skills they have learned 
in their own living environment.62 
2.2.2 General Conclusions on Home-Based Rehabilitation  
A number of published studies have examined patient outcomes following home-based stroke 
rehabilitation. Although these studies vary in program structure, process, and outcomes assessed, 
they generally concur on the ability of home-based, specialized, interdisciplinary, stroke 
rehabilitation services to produce significantly positive outcomes in stroke patients similar to 
those seen in traditional hospital-based, outpatient programs. Although the majority of these 
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studies did not demonstrate superior improvements when compared to traditional services, the 
preponderance of analyses demonstrated significant improvements in level of disability, 
psychosocial well-being, caregiver outcomes, general health and well-being, and a variety of 
other positive benefits in study groups who received home-based rehabilitation compared to 
baseline. This supports the evidence base for the efficacy of home-based stroke rehabilitation. 
However, evaluations of ongoing programs are warranted to further validate the efficacy of this 
treatment approach. 
 
 The Cost of Stroke in Canada 
The costs of stroke to the Canadian economy are enormous. An estimated $3.6 billion is incurred 
each year due to both the direct and indirect costs of stroke.63 Although the majority of costs are 
related to acute and inpatient care, a substantial amount is attributed to post-acute rehabilitation, 
stroke prevention, and physician visits for both primary stroke follow up and attributed medical 
comorbidities such as depression, urinary tract infections, and pain.64 A recent systematic review 
found an estimated 30.0-62.2% of individuals will be readmitted to hospital following post-acute 
care for all cause morbidity, and an additional 20% of stroke survivors will experience a recurrent 
stroke,1 resulting in considerable added cost  to the health care system. An estimated 80% of 
costs during the first six months following stroke are direct costs to the health system.63 
A recent Canadian study, The Economic BURden of Ischemic STroke Study (BURST),65 examined 
the cost of ischemic stroke in Canada over a one year period. This study demonstrated that the 
average per person cost of a stroke in Canada over a one year period is approximately $75,000, 
with disabling stroke being almost twice the cost of nondisabling strokes. Furthermore, during 
the acute phase of recovery, nearly half (46.8%) of these costs are attributed to hospital admission 
with rehabilitation costs constituting a large portion (34%). Post discharge from hospital, indirect 
costs, such as lost productivity and out of pocket expenses, become the highest contributor 
(58.3% at 4-6 months, and 42.3% at 7-12 months post stroke). This high cost of stroke is an 
enormous burden to both the health care system and the stroke survivor during this one year 
period.  
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Recently, it has been postulated that optimization of stroke care systems in Canada throughout 
the stroke care continuum could dramatically impact stroke costs related to stroke, reducing the 
yearly economic burden of stroke by as much as $682 million annually, including $307.4 million 
in direct and $374.3 million in indirect costs.66 This may be accomplished through the 
implementation of evidence based stroke care in the acute phase, through organized stroke units, 
and through home supported discharge.  Furthermore, the estimated 286 000 Quality Adjusted 
Life Years (QALY) lost annually to stroke could be decreased by as much 10 568 QALYs.66  
Post stroke disability level also has a considerable impact on post stroke costs. This has been 
demonstrated by the BURST study65 in a Canadian context as discussed above. Dawson et al.67 
also demonstrated an incremental increase in health care utilization costs with increased disability 
level as measured by the modified Rankin Scale. This impact of disability level on stroke costs 
has been demonstrated in a number of international studies, and is largely due to the increased 
use of care services, institutionalization, and hospital admissions by individuals experiencing 
more disability.68-71  
In addition to costs to the health care system, stroke patients and their families experience a 
negative economic impact. This may largely be due to loss of productivity in the form of lost 
wages for both the stroke survivors and their caregivers, at least during the period of acute 
recovery, and an estimated 27-81% of individuals are unable to return to work at all.72 Travel 
costs for doctor visits and outpatient rehabilitation may also accumulate to a large degree. 
Furthermore, stroke patients may seek the services of private therapists, accruing personal costs 
for these services.  The majority of these indirect costs are incurred during the post-acute phase, 
following discharge from inpatient stroke care.63 
Post-acute rehabilitation is vital to reduce the adverse effects of the stroke, improve quality of 
life, decrease the need for activity of daily living supports, support return to work, reduce the 
severity and number of stroke co-morbidities, and decrease the risk of recurrent stroke.5 In effect, 
the reduction of these adverse consequences of stroke will help alleviate some of the burden of 
costs of stroke to both the health care system and to stroke survivors and their families.  
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 Economic Evaluations of Home-based Rehabilitation  
Few economic reviews have examined the costs of home-based programs in the post-acute stage. 
The majority of these studies examined the costs of these programs in the context of an early 
supported discharge program. Far fewer looked at cost differences in comparison to hospital-
based outpatient programs.  
Most studies have found that home-based services are no more costly than outpatient hospital-
based programs, and in some cases are more cost-effective. Roderick et al.73  looked at both 
health and social service costs accrued by participants during the study period and found that 
there were no statistically significant differences between those accessing in-home rehabilitation 
and individuals in an outpatient program.  While similar overall health service costs were 
observed in the two groups, slightly higher social service costs were noted in the home-based 
group. Similar cost outcomes were also noted by Gladman et al.,74 with slightly lower health 
service costs observed in the hospital-based cohort. Bjorkdahl et al.58 also examined the costs of 
home-based rehabilitation as an alternative to an outpatient hospital program. This study solely 
examined the costs of the two programs themselves, and did not include any additional health 
care costs.  The authors found that the program cost of home rehabilitation was less than half 
(42%) of hospital based rehabilitation. Anderson et al.42 conducted a systematic review of the 
economic impact of home-based rehabilitation programs, including those with an early supported 
discharge component, and found that, overall, home-based rehabilitation reduced hospital stays 
by 13 days (95% CI: -19 to -7 days). Furthermore, overall mean costs for community stroke 
rehabilitation care in combination with early discharge from hospital resulted in an overall mean 
cost reduction of 15% without compromising patient outcomes.42  
Recently, a Randomized Controlled Trial26 was conducted in Ontario, Canada examining home-
based stroke rehabilitation provided by the Community Care Access Centre (CCAC), an agency 
that coordinates home care services for individuals with activity of daily living difficulties.75 This 
program has sometimes been called ‘Enhanced CCAC’ and offers an interdisciplinary approach 
to in-home stroke rehabilitation. In this study, individuals were randomized to receive either the 
Enhanced or the traditional level of CCAC services, with minimal access to additional stroke 
services. Authors aimed to answer the question of whether this 12 month specialized stroke 
rehabilitation program improved quality of life and functioning, in addition to evaluating costs. 
22 
 
 
 
Assessments were completed at baseline and 12 month follow-up.  Cost analysis of the program 
revealed a slightly although not significantly higher per person cost in the use of health services 
for the intervention group as measured by the Health and Social Services Utilization Survey. It 
was concluded that this program is a feasible approach to traditional outpatient services. It was 
noted, however, that a small sample size (N=101), may have resulted in an unrepresentative 
sample. Furthermore, a greater length of follow-up time may be important to detect differences in 
the cost of health resource utilization over the long-term. This Ontario based study is an excellent 
example of the cost-effectiveness of home-based stroke rehabilitation in the Canadian context.26 
In general, there is substantial heterogeneity of results when examining the effectiveness of 
home-based stroke rehabilitation programs in terms of patient outcomes in relation to cost 
savings.76 This is likely due to the fact that the majority of studies examining home-based 
rehabilitation for stroke patients differ on aspects of the programs themselves, structure of the 
interdisciplinary teams, as well as the differences in health care system structures between 
countries around the world. Furthermore, studies generally have small sample sizes and limited 
follow up. This may also have implications for extrapolating the effectiveness of results and the 
cost implications to the Canadian context.  
 
 Gaps in the Current Evidence  
Although there are a number of studies that support the effectiveness of home-based 
rehabilitation programs, few were able to demonstrate a great deal of added benefit when 
compared with traditional hospital-based rehabilitation services. This suggests that in-home 
rehabilitation is comparable to outpatient rehabilitation in its effectiveness; however, it does not 
provide a definitive indication of whether this approach is superior to no therapy. Given that 
home-based rehabilitation has been found to be likely non-inferior to hospital-based outpatient 
services, and hospital-based programs have been demonstrated to be effective at improving 
patient outcomes, it can be inferred that home-based programs are of benefit. For the large 
number of individuals who are discharged from inpatient stroke care with no further services, 
access to a home-based program may be of particular value and should be the subject of further 
study in this context. 
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This same problem is encountered when considering economic evaluations of such programs. No 
studies have been published evaluating the cost-effectiveness of a home-based stroke 
rehabilitation program in comparison to a cohort of individuals who are not able to access any 
further rehabilitation services. This is an important consideration as it is imperative from a policy 
and funding standpoint that such a program is, in fact, worth the resource contribution. 
Furthermore, no studies have been conducted examining the projection of long-term costs and 
benefits of such a program in any context.  
Studies in the current literature are also difficult to compare. Interdisciplinary team structures, 
length and intensity of services, and approaches implemented vary widely. Furthermore, 
characteristics of comparison groups in Randomized Controlled Trials vary just as widely, adding 
an additional challenge. Cost analyses that have been completed are also very heterogeneous, 
varying drastically across geographic and health care settings, and are often based on small 
sample sizes and diverse stroke populations. This makes it very difficult to extrapolate results of 
these studies to existing programs. This emphasizes the importance of evaluations of individual 
programs in terms of both program costs and outcomes, to assess the overall efficacy and cost-
effectiveness of specific program approaches.  
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3 Objectives 
The Community Stroke Rehabilitation Teams represent a unique model of care. Rehabilitation 
programs similar to the CSRT have yet to be fully evaluated in an economic context. In 
particular, comparisons to a cohort receiving No Therapy are limited. Comparison to a No 
Therapy population is relevant in the CSRT context as, for the majority of CSRT clients, 
alternate rehabilitation services are not available. Additionally, there are no long-term projections 
of cost-effectiveness of a home-based stroke rehabilitation program in any context. 
As such, the objectives of this analysis are:  
1. To determine the long-term costs and consequences of a home-based stroke rehabilitation 
program, Ontario’s Community Stroke Rehabilitation Teams. 
2. To determine the long-term cost-effectiveness of the Community Stroke Rehabilitation 
Teams compared to a cohort receiving no further rehabilitation therapy.  
 
 Hypothesis 
We hypothesize that a long-term projection of the costs and consequences of the CSRT model of 
care will reveal it to be cost-effective when compared with No Further therapy.  
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4 Methods 
The purpose of this chapter is to provide a brief background to the terms used and the rationale 
underlying economic evaluations of health care programs, devices, drugs and other interventions.  
This chapter will also provide a detailed methodology of the approaches taken to develop the 
economic model used in this analysis 
 
 Introduction to Economic Analysis 
Economic evaluations are an important aspect of most decisions in health care.  Drummond et al. 
define economic evaluation as “the comparative analysis of alternate courses of action in terms of 
both their costs and consequences.”77(p.9) Modelling in economic evaluations is valuable to inform 
decision making processes, guide clinical practice, and optimize the use of health care 
resources.78 
4.1.1 Types of Economic Analysis 
There are four main types of economic evaluations: cost-minimization, cost-benefit, cost-
effectiveness, and cost-utility.  While all four approaches can aid decision making and be 
invaluable to policy makers and decision support personnel, they differ in terms of their 
applications.  
Cost-minimization analyses simply look at the costs of a program, irrespective of any benefit or 
outcome it may produce. In cost-minimization analyses the underlying assumption is that there is 
no difference in health outcomes between the two comparators and thus only the cost difference 
is relevant. Cost-effectiveness analysis and cost-utility analysis differ from the cost-minimization 
analysis in that both costs and outcomes are compared between programs. In a cost-effectiveness 
analysis, outcomes are the same between programs, allowing for direct comparison, and 
outcomes are measured in natural units such as life years saved, blood pressure reductions, and 
hospital admissions. In a cost-utility analysis, outcomes incorporate a measure of utility, in order 
to calculate a Quality Adjusted Life Year (QALY) (See section 4.1.3). This enables direct 
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comparison of outcomes using a comprehensive summary measure that reflects both the length 
and quality of life. When conducting an economic evaluation, one must consider what 
information is available to determine the most appropriate form of analysis.77 Finally, a cost-
benefit analysis incorporates the benefit gained from a program into the results of the analysis by 
using a monetary value of benefit. In cost-benefit analyses, willingness to pay for health 
outcomes signifies the value of the outcome.  
4.1.2 Perspective 
Perspective is also an important consideration in cost analyses, as the perspective taken must aim 
to answer the research question of the evaluation.78 Most economic evaluations take the 
perspective of the payer or funding body (payer perspective). In other cases, a wider perspective 
may be examined looking at the cost to society as a whole (societal perspective), which includes 
the costs to clients or patients. Each analysis may consider different sources of cost and potential 
benefits of a program in accordance with the specific objectives of each research question.79 
Direct costs refer to resources consumed by the program in the health sector. These are often 
costs to the health care system, or to the funding source. This term may also refer to expenses 
paid out of pocket by a patient such as travel and parking, assistive devices, and additional 
treatments required that are not covered by their health insurance. Patient costs are often 
separated into a separate category known as patient out of pocket costs. Indirect costs are those 
that do not typically have a direct monetary value, such as time gained or, conversely, lost from 
work.77  
Similarly, outcomes of interest of a particular program or treatment often depend on the target 
audience of the analysis. Direct patient consequences such as impact on function and quality of 
life may be of interest to society as a whole and to the individuals affected by the treatment. 
Conversely, outcomes related to the impacts of a program on a health system, such as the number 
of days spent in hospital or number of diagnostic tests performed, may be of more interest to a 
funding body and decision or policy makers. 
4.1.3 Health Utility Measurement and QALYs 
Outcomes and effects of a particular treatment are important aspects of the evaluation of the 
impact of a program or intervention. The effectiveness of a program can be measured in several 
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ways: program specific outcome measures, generic outcome measures, and preference based 
measures. Preference based measures often use either standard gamble or time trade off methods 
to determine how much individuals would be willing to sacrifice to avoid a particular state of 
health, or how one type of outcome compares to another.80 This results in a utility value anchored 
between 0 and 1.0, with 1.0 representing perfect health, and 0 typically representing death.77 
These measures are of particular value when conducting economic evaluations, as they can often 
be converted to a measure of quality of life in the form of a Quality Adjusted Life Year 
(QALY).81  
QALYs are calculated by multiplying the utility of a particular health state by the length of time 
spent in that health state.  This is a widely used method that is clearly understood, easy to use and 
interpret, and has good face validity.81 QALYs are also a useful tool as they consider both gains 
from reduced morbidity, as well as increased mortality.77 Furthermore, the generation of a QALY 
allows for a more direct comparison of treatments for different health conditions that may also 
have different natural outcomes because it provides a comprehensive measure of benefit.  
4.1.4 The Value of Economic Modelling  
Because it is usually not financially or logistically feasible to conduct long-term studies lasting 
decades, in the majority of cases it is necessary to construct a mathematical model to extrapolate 
the long-term costs and benefits of a program.  This is especially the case with costly 
Randomized Controlled Trials. Modelling is a valuable approach to using information gained 
from short-term studies in the context of what is understood about the natural history of a disease.  
To do this, a common practice is to gather additional information from literature-based sources 
(observational and longitudinal studies), databases and registries, expert opinion, and from 
reasonable assumptions made by the authors of the study.81 Furthermore, many observational 
studies do not include a control population and, as such, one must be constructed using literature 
based estimates. It is, however, important to consider the model objective, source quality, and 
relevance of the included information when incorporating it into the model. Furthermore, it is 
imperative to be transparent regarding all assumptions, and the methods of handling and 
transforming the incorporated data for use in the model should be described in detail.81 
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4.1.5 Challenges in Modelling  
When identifying sources to be used to inform a model, it is rare to find information on the exact 
population of interest or study results provided in the most appropriate format. As such, one must 
aim to incorporate the most suitable sources, and transform any information into a usable format. 
It is crucial to remember that the research question, not the availability of data, should inform the 
model structure.81  
Finding a comparable population is a particular challenge. Variations in clinical practice, 
geographical considerations, availability of resources, and differing health systems and policies 
may impact treatment or program comparability. Study participant characteristics and strict study 
inclusion criteria may also impact the generalizability of a sample result. Furthermore, aspects of 
study design such as outcome measures used, time horizons, and health state definitions may 
differ from those required for modelling purposes.81  
Additionally, data of interest may not be in the most appropriate or consistent format for use in a 
specific model. This may require some recalculating on the part of the researcher building the 
economic model. Often, rates need to be transformed into probabilities, and probabilities from the 
literature need to be adjusted to the time frame of the model. Costs may need to be converted to a 
relevant currency and inflated to reflect the appropriate year. Extrapolating long-term effects 
from short term study data is another common approach. In long-term model projections, it is 
optimal to include a lifetime time horizon.78 This is particularly important for chronic 
conditions.81 It is important to state any assumptions made when transforming data in such a way, 
and to be transparent regarding approaches taken.81  
When developing a model, other considerations must be taken into account. Discounting of costs 
and utility values is a common approach to correct for ‘real world’ applicability.  Discounting 
takes into consideration that people generally value costs and outcomes more highly in the 
present than they will in the future. Discount rates differ for each country and range from 3-5% 
per year.77,82 Opportunity costs must also be considered. Opportunity cost is an economic concept 
that indicates the best estimate of the value of a resource is the cost associated with the next best 
use of the resource.77 The value of time loss due to illness is an opportunity cost. An individual 
could use the time for work or leisure. The opportunity cost of time is a cost from the economic 
perspective, but may not have monetary implications. For example, individuals are not paid for 
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leisure time, but lost leisure is considered important from an economic perspective because there 
is a lost opportunity to use this time in an alternative way.77 
4.1.6 Markov Models 
Markov modeling is a commonly used approach for projecting the long-term impacts of health 
care programs and interventions. This is of particular value when considering long-term and 
chronic diseases. This modeling approach allows individuals to transition between a set of 
mutually exclusive health states. Health states may be defined as a specific health outcome (i.e. 
cancer remission), physiological events, or even health indices such as quality of life.78  The 
proportion of individuals in each health state at any given time throughout the time horizon of the 
model is determined by the starting distribution and the per cycle probability of transitioning 
amongst the health states - or remaining in the same health state - with each phase of the model. 
It is assumed that an individual can only make one transition during each cycle.82 The majority of 
Markov Models contain at least one state that a person cannot leave, most often death. This is 
called an absorbing state, and is essential for the Markov process to terminate.  
The time horizon of the model is divided into equal increments of time called cycles. A cycle 
length is determined by considering what is clinically appropriate for what is being modeled and 
the specific research question.81,82 Cycles may be measured in terms of hours, days, weeks, 
months, or even years.  
Each health state is assigned a specific cost and utility value. These values can change with each 
cycle of the model.  For example, health resource use consumption may change over time, 
resulting in a lower cost per cycle. Total costs and QALYs are calculated based on the proportion 
of individuals in each health state over the life of the model.77 The model is realized for each 
treatment that is being compared. This results in a total cost for each treatment, a total QALY and 
the incremental cost per QALY associated with improvements in health of one treatment 
compared to another. Markov models can be projected for a pre-specified length of time, 
providing an indication of the long-term impacts of a program.  
Markov models are often represented by state transition diagrams (Figure 4.1). Each circle 
represents a health state, with either uni or bi-directional arrows identifying the ways an 
individual may transition between states, or remain in the same health state.82 
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Figure 4.1: Example of a State Transition Diagram 
Although models aim to mimic outcomes over the course of time, they cannot perfectly duplicate 
what happens in a real world situation. However, a model may incorporate several approaches to 
help correct for some of this real world variation.  For example, it can be assumed that transitions 
will not occur exactly at the beginning of each new cycle but will occur at some point during the 
cycle. As such, half cycle corrections are often applied to models by adding one-half of the costs 
and QALYs accumulated in the first cycle prior to beginning the Markov simulation, and adding 
one-half of the costs and QALYs accumulated in the last cycle, at the end of the Markov 
simulation. In this way, an assumption is made that each transition will occur half way through 
each cycle, aiming to balance, on average, over or under-estimations of proportions of individuals 
in each state.82  
4.1.7 Uncertainty in models 
Given the challenges with developing economic models, it is imperative to quantify the amount 
of uncertainty present. This is particularly of value when using a variety of data sources. This is 
best done by completing extensive sensitivity analysis to assess parameter uncertainty.81 
One-way and two-way sensitivity analysis, also known as Deterministic Sensitivity Analysis 
(DSA), are appropriate ways of assessing uncertainty in the model parameters. This may refer to 
assumptions made by the modeler, the choice of the model structure, calculation techniques used 
(i.e. extrapolation methods), and variability between data sources. Parameter uncertainty refers to 
the variability around the model parameters including cost inputs, utility values, and transition 
probabilities.81,83 DSA examines how sensitive the final model results are across a range of 
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parameter values for each input. A reasonable and justifiable range of values to assess the full 
extent of variability should be assigned to each model input.81 
Probabilistic Sensitivity Analysis (PSA) is most suitable for examining the joint parameter 
uncertainty in a model and to investigate overall robustness to changes in input values. PSA using 
Monte Carlo simulation is of particular value. In this way, sampling distributions are assigned to 
each parameter based on parameter characteristics.  A number of microsimulations are then 
completed wherein a value is chosen at random from each parameter distribution and run through 
the model.83  
 
 Detailed Methodology 
The economic evaluation method used in this thesis is a long-term projection of costs and 
consequences using Markov modelling, employing many of the economic evaluation techniques 
and considerations described above. This section describes in detail the use of these techniques to 
build the model.  
A version of the following will be included as a supplement to the manuscript to be submitted to 
Stroke. 
4.2.1 Markov Model Development   
In order to project the long-term costs and effects of stroke, we developed a Markov Model. This 
model consists of a decision tree, comparing either intervention from the CSRT program, or a 
cohort who assumed to have received no further rehabilitation therapy services (Figure 4.2). The 
model consists of four possible health states which are described in Table 4.1: Nondisabled, 
Disabled, Long Term Care, or Death. The Markov Model itself is depicted in Figure 4.3. The 
model time horizon we used is 35 years with six month cycles. The perspective taken was 
societal as costs to the health care system, private insurance, and patient out of pocket expenses 
were considered. However, it should be noted that lost productivity and leisure time costs were 
not accounted for.  
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Figure 4.3: Markov model 
 
 
 
 
 
 
Table 4.1: Definition of health states in Markov model 
Health State Description 
Non-disabled  An individual is able to live completely independently, in their 
own home, while being completely independent in their activities 
of daily living 
Disabled An individual is able to live in their own home, but requires 
assistance for activities of daily living either from a family/ friend 
caregiver or from home care services (i.e. Community Care Access 
Centres) 
Long Term Care An individual resides in a Long Term Care or assisted living 
facility and is no longer capable of residing in their own home 
Death The final absorbing state in the model 
  
 
 
 
 
 
Stroke (discharged 
from hospital) 
No further therapy 
Community Stroke 
Rehabilitation Team 
Markov Model 
Markov Model 
 
 
 
 
 
Non-disabled  
 
Long Term 
Care 
 Death 
 
Disabled  
Figure 4.2: Decision tree for cost-utility analysis 
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4.2.2 Data Sources 
Because of the unique nature of the Community Stroke Rehabilitation Team program, as well as 
the context in which it operates, it was necessary to draw on a number of sources to populate the 
parameters of our Markov Model.  The vast majority of Randomized Controlled Trials examining 
the effectiveness of home based programs, similar to that of the CSRT, often compare outcomes 
to those of a similar population receiving hospital based outpatient care. Because the aim of the 
CSRT program is to provide services to individuals who would not otherwise have access to any 
rehabilitation (or very limited access), it was not appropriate to draw on these sources as a 
comparator. As such, we relied mainly on large population based studies. Additionally, the one 
year time frame of the CSRT Economic Study was not sufficient to determine any long-term 
cost-effectiveness of the program. As such, the combination of primary and literature based 
sources also allowed us to project over the long-term using a model.  
A comprehensive search was undertaken using multiple electronic databases (i.e. PubMed, 
CINAHL) to identify articles on the natural history of stroke. Identifying longitudinal studies 
with similar stroke populations was the aim of these searches. Furthermore, studies reporting data 
to appropriately inform our model parameters were targeted (i.e. results presented by disability 
level).  
A summary of these sources by study time frame is presented in Table 5.1 in the following 
chapter. Four main sources were used to populate the parameters of the model:  
Community Stroke Rehabilitation Team Economic Evaluation Study Data (N=212) 
Details of the CSRT Economic study are provided in Chapter 5. Funding for this study was 
provided by the Ontario Stroke Network and the study was conducted in collaboration with the 
CSRTs. The original study design involved the recruitment of control subjects from elsewhere in 
the province of Ontario (i.e. outside of the South West LHIN). Hospitals across the province with 
large volumes of patients discharged with no access to further rehabilitation service were 
provided with recruitment training, and contacted on a weekly basis to provide support and 
obtain contact information for recruited patients. Patients who had no access to further 
rehabilitation, but who would benefit from additional therapy were it available, were targets of 
these recruitment efforts. Control participants were to be assessed in the same way as CSRT 
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study participants. Unfortunately, due to very low control participant recruitment, only CSRT 
participant data were available for analysis. Participant flow through the study is detailed in 
Appendix 1.  
Markle-Reid et al. (2011) - Interprofessional Rehabilitation for Stroke Survivors Using Home 
Care26  (N= 101) 
This study, conducted by researchers at McMaster University in Ontario, Canada, was a 
Randomized Controlled Trials examining the effectiveness of a home based stroke rehabilitation 
program compared to traditional home-based care (i.e. Community Care Access Centre) with no 
rehabilitation.  Participants were assessed at baseline and 12 month follow up on function and 
psychosocial outcomes (Stroke Impact Scale-16), as well as health service utilization using the 
Health and Social Services Utilization Survey. Individual level data were obtained for use in the 
present analysis. Because the control group in this study was similar to the intended control 
population in the original CSRT study design, data from the control group (n= 49) was 
incorporated into the Markov model.  
Canadian Community Health Survey (2010)84 (N= 61,707) 
The Canadian Community Health Survey (CCHS) is a nationwide, cross sectional survey 
designed to collect information regarding health care usage and the health status of a 
representative Canadian population from diverse demographic and socioeconomic backgrounds. 
It includes information on individuals over the age of 12, and randomly samples the entire 
Canadian population across all 10 provinces and 3 territories.  Individual level datasets are freely 
available. For the purposes of this study, only individuals replying ‘yes’ to the question ‘Do you 
suffer from the effects of a stroke?’ (CCC_151) were included in the analysis (N= 993).  
Literature Based Sources 
1. Magalhaes et al. 2014 - Functional Status Three Months after the First Ischemic Stroke Is 
Associated With Long-Term Outcome: Data from a Community Based Cohort85 (N= 380) 
This Portuguese population based study85 examined first ever stroke survivors over a period of 
seven years. Patients were contacted at 3 months, 1 and 7 year follow up times, and long-term 
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functional status and survival was assessed. Deaths were reported by family members or derived 
from computerized patient files.  
2. Oxford Vascular Study (N= 748 stroke patients) 
The Oxford Vascular Study is a UK population based study which followed patients for up to 5 
years post stroke. Patients were assessed at 1, 6, 12, 24, and 60 months post stroke. A range of 
demographic characteristics and patient outcomes were assessed at each time point. Several 
publications have resulted from this study including articles examining quality of life in these 
individuals using the EQ-5D86, as well as admission to Long Term Care facilities87.  
3. Perth Community Stroke Study88 (N=328) 
The Perth Community Stroke Study is a population based study conducted in Perth, Australia. 
Patients with stroke were followed for a period of 10 years, and were assessed on disability, new 
stroke, and living arrangements.  
4. Ontario Based study of LTC Residents 89,90 (N= 8,058) 
This study is an Ontario, Canada based study of LTC residents assessing the cost-effectiveness of 
various pressure ulcer prevention strategies. The study population included all residents in 89 
Long Term Care facilities across Ontario. The Resident Assessment Instrument – Minimum Data 
Set (RAI-MDS), which is collected on patients on a quarterly basis, was used to assess changes in 
physical functioning, cognition, health status, and quality of life. Costing data for this study were 
derived from the Ministry of Health and Long Term Care, Ontario Health Insurance Plan, 
Canadian Institute of Health Information – Discharge Abstract Database, and the National 
Ambulatory Care Reporting System. 
4.2.3 Health State Definitions 
Individual Level Study Data & Literature Based Sources 
Both the CSRT study and the study by Markle-Reid et al.26 administered the Stroke Impact Scale-
16 (SIS-16) to participants. This measure was used to differentiate between Disabled and Non-
Disabled health states. Several validation studies have demonstrated good ability of the SIS-16 to 
differentiate across levels of the modified Rankin Scale.51,52 As such, a score of <75 on the SIS-
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16 was considered to be Disabled, and ≥75 Non-Disabled. These cut-offs are consistent with 
definitions of disabled and non-disabled found throughout the stroke literature.85-87  
Throughout the literature, the modified Rankin Scale (mRS) is consistently used as a measure of 
disability following stroke. In all literature based model inputs, an mRS of ≥3 is considered to be 
Disabled, where as a score of <3 is Non-Disabled.85-87 
Canadian Community Health Survey 
The CCHS asks a number of questions relating to physical functioning and restriction of 
activities. The variable ‘Participation and Activity Limitation’ (RACDPAL), classifies 
individuals based on the frequency with which they experience difficulty as a result of a long-
term or chronic health problem (lasting >6 months). It is derived from five questions, all 
pertaining to restriction of activities. For the purposes of this study, a classification of ‘never’ 
was considered to be a Non-Disabled individual, and a mean of the ‘sometimes’ and ‘often’ 
classifications were considered to be in the Disabled health state.  
4.2.4 Cost Inputs 
Costing of health services employed the ingredients approach, in which the frequency of 
utilization of health services was multiplied by the price. A breakdown of costs for both the 
CSRT and No Therapy cohorts are detailed in Appendix 2.  
Community Stroke Rehabilitation Team Intervention 
Health care usage costs for the Community Stroke Rehabilitation Team were derived from data 
collected using the Health and Social Services Utilization Survey (HSSUS) at six and 12 month 
follow up. Cost estimates for health care usage were derived from the costing manual 
accompanying the HSSUS and are based on the Ontario Health Insurance Plan (OHIP) schedule 
of benefits and fees. Laboratory and diagnostic fees were provided in 2003 Canadian Dollars, and 
all other services in 2006 Canadian Dollars. As such, costs were inflated to reflect 2013 Canadian 
Dollars using the Ontario health and personal care consumer price index inflation rates91. Where 
specific costing information was not available (i.e. community services, devices, medical 
supplies), the midpoint of the highest and lowest cost estimate from two online Canadian sources 
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was averaged. Travel costs to health care appointments incorporated the cost of parking, cost per 
kilometer to destination, hotel stays, and the cost of taxi service or public transit. Costs included 
for use in this analysis were physician visits (including Emergency Room (ER) visits and 
specialists), other health care professionals/ services, hospitalizations and surgeries, diagnostic 
tests and laboratory expenses, devices and special treatments, household help, and travel costs.  
Visit costs for the CSRT program were provided by the program itself. Each visit cost included a 
proportion of program overhead, therapist cost, as well as any associated therapist travel costs. 
Per visit cost calculations were specific to therapist type (physiotherapist, occupational therapist, 
speech-language pathologist, recreational therapist, rehabilitation therapist, social worker, or 
registered nurse), and CSRT location (Huron Perth, Thames Valley, or Grey Bruce). Because of 
the delay in contact between the initiation of CSRT services and baseline contact, as well as 
possible client recall bias, the number of visits a client had with CSRT care providers was 
derived from the CSRT administrative database. This data source contained all visits the client 
received during their time in the program.  
Participant costs at each time point were totaled, and means calculated for each health state. Costs 
were applied for the first two cycles in the CSRT arm.  
No Further Therapy Comparator 
Health care usage for the comparator group was derived from the study conducted by Markle-
Reid et al. 26 at McMaster University. As with the CSRT study, frequency and type of health care 
usage were collected using the HSSUS. The same unit costs used to estimate CSRT health care 
costs were applied to this data. Because the HSSUS asks about health care usage (general 
practitioner/specialist visits, other health services etc.) in the past six months, and only 12 month 
follow up data were available, proportions of health care usage in the first vs. second six month 
periods from CSRT data were used to determine a cost estimate for the first six months. 
Hospitalization data for this study was available for the whole 12 month period, therefore costs 
for the first vs. second six month time period were similarly calculated from proportions of CSRT 
hospitalization costs during each time period. As with CSRT data, costs included for use in this 
analysis were physician visits (including ER and specialists), other health care usage, 
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hospitalizations and surgeries, diagnostic tests and laboratory expenses, devices and special 
treatments, household help, and travel costs.  
Participant costs at each time point were totaled, and means calculated for each health state. Costs 
were applied for the first two cycles in the comparator arm.  
Long Term Care (LTC) 
Cost for an individual living in Long Term Care were derived from an Ontario based economic 
study90 of pressure ulcer interventions in LTC. Mean weekly costs of Long Term Care (nursing/ 
personal care, physician costs, other), hospitalizations, emergency department visits, and 
diagnostic tests were totaled to produce a six month cost estimate.  
Long Term Care costs were the same applied for the both the CSRT and comparator arm for the 
duration of the model 
Long-Term Projection  
Questions pertaining to health care utilization in the CCHS were isolated, and a cost per visit 
applied based on costing data used in CSRT study. Where specific health care professional 
information was not available, a mean cost was applied (i.e. the mean cost of a specialist). 
Because type of surgery received was not specified, the mean cost of outpatient surgery from 
CSRT data was applied to individuals stating they have received non-emergency surgery. This 
was felt to be appropriate as any additional costs of an overnight stay due to surgery would be 
captured in the “number of nights as patient’ question (CHPG02). Cost of diagnostic tests, if 
received within the last year, were also calculated. Because some questions did not report the 
frequency of usage (i.e. diagnostic tests, surgery), these costs were applied only once. Questions 
pertaining to travel expenses, household help, and the cost of devices were not available. As such, 
the mean of all household help, travel expenses, and device costs from both CSRT data and the 
Markle Reid et al.26 study were added to each estimate.  
Costs were totaled for each study participant, and means calculated for each health state. Cost 
were applied beginning in the third cycle of the model for both the CSRT and comparator arms. 
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4.2.5 Transition Probabilities 
All transition probabilities used in the model are detailed in Appendix 3.  
Community Stroke Rehabilitation Team Intervention 
Based on health state definitions, as determined by the SIS-16 data collected during the CSRT 
study, the proportion of individuals in each health state (Disabled and Non-Disabled) and 
transitioning between health states between baseline and six month follow up, and six and 12 
month follow ups was determined. These probabilities were applied to the first two cycles of the 
model. 
No Further Therapy Comparator  
Based on health state definitions, as determined by the SIS-16 data collected during the Markle-
Reid et al.26 study, the proportion of individuals in each health state and transitioning between 
health states between baseline and 12 month follow up was determined. Because only the 
cumulative probability of transitioning between health states was available, this probability was 
converted into a per cycle rate using the formula: 
(Formula A) r = ln(-S(t))/ t 
Where r is the per-cycle rate, S(t) is the cumulative probability, and t is the number of cycles. 
This per cycle rate was then transformed back into a per cycle probability to reflect the cycle 
length of the model using the formula: 
(Formula B) p = 1 – exp(-r*t) 
Where p is the per cycle probability, r is the per-cycle rate, and t is the number of cycles. 
These probabilities were applied to the first two cycles of the model. 
Long-Term Projection  
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We estimated the annual probability of death, admission to Long Term Care, and new disability, 
by converting cumulative survival to time t, to a per cycle rate (Formula A). We then converted 
the per cycle rate to a per cycle probability using the formula (Formula B) 
New Disability: A long-term estimate of functional decline was derived from the Perth 
Community Stroke Study. From a 10 year cumulative probability of new disability, an annual 
rate was calculated. Research on outcomes following stroke almost exclusively demonstrate 
functional decline as time post stroke onset increases.88,92 Therefore, it was assumed that after 1 
year, individuals would no longer transition from the Disabled to Nondisabled health state. This 
probability was applied following the third cycle of the model and projected forward for the 
duration of the model. 
Death and admission to LTC: Using Kaplan Meier survival data from two studies85,87 cumulative 
survival (S(t)) values were transformed into per cycle probabilities. To extrapolate beyond the 
study period, a linear regression model was developed using all observed study data. This was 
done by taking the ln of each S(t), and regressing this on survival time (t) in months. The 
resulting intercept and β coefficient (λ) were entered into the equation S(t)= exp(-βo-β1(t)), varying 
the value of t for each extrapolated time point of interest to obtain the S(t) at that time point. 
These S(t) values were then used to calculate the per cycle probability. Calculated values of 
probability of death were used for the duration of the model.  
Death in LTC was determined using unpublished data from Hillmer (2008) of the six month 
cumulative incidence of mortality in LTC residents.90 
4.2.6 Utilities  
All utility values used in the model are detailed in Appendix 3.  
Community Stroke Rehabilitation Team Intervention 
Patient responses to the EQ-5D-5L were used to generate a health state profile that can then be 
converted to index based values. For the purposes of this study, the United States value set was 
used. Mean utility values for each health state were calculated for each time point. Utilities were 
applied to the CSRT arm for the first three cycles of the model  
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No Further Therapy Comparator  
Data from the Oxford Vascular Study were used to calculate a trend in health utilities over a 5 
year period for both Disabled and Non-Disabled health states. This trend was then applied to the 
mean baseline CSRT utility for both Disabled and Non-Disabled health states in six month 
intervals and projected to the end of the study data (10 cycles of the model). This trend was 
applied to CSRT study data following the third cycle of the model.  
For the purposes of this model, health state utilities differed between the intervention and 
comparator arms for the first 10 cycles of the model. This was done to reflect the effect of the 
intervention on one’s Health Related Quality of Life during the period of intervention, as well as 
the continued effect it may have on patient well-being. Following this period, utility values were 
constant between intervention and comparator arms.  
Long Term Care 
Mean utility values for all individuals in LTC were derived from the Ontario based study by 
Pham et al. (2011) and applied for the duration of the model. 
Long Term Projection  
Health utility indexes by five year age range are provided in the CCHS (2010). Beginning with 
the mean CSRT cohort age, and following the 5 year Oxford Vascular Study data, mean utilities 
for each health state and age range were projected forward for the remainder of the model 
4.2.7 Cost-Utility Analysis  
A cost-utility analysis was conducted to determine the incremental cost of the CSRT program per 
Quality Adjusted Life Year (QALY) gained as compared to a control group. Upon inputting 
model parameters determined using the above methods, the model was run in six month cycles 
for a total length of 35 years (70 cycles) or until death.  The total expected value of cost and 
accumulated QALYs were estimated for each cohort. Costs and QALYs were compared for 
CSRT versus No Therapy. 
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4.2.8 Sensitivity Analysis 
One-way: To assess uncertainty in the model, one-way sensitivity analysis was completed on all 
parameters. Reasonable input ranges were determined from 95% confidence intervals for utilities 
and transition probabilities. Ranges for cost parameters were determined by taking 95% CI of the 
means and standard deviations of the log transformed costs for each cycle, and using the smallest 
and largest values for the upper and lower range value, respectively (Appendix 4). Further 
threshold analyses were conducted on all sensitive parameters to determine the exact value at 
which the treatments had equal costs.  
Two-way: In a two-way sensitivity analysis, two model parameters are changed simultaneously. 
For this model, two-way sensitivity analyses were conducted on key model parameters: the cost 
of being Disabled and the probability of transitioning between Disabled and Nondisabled health 
states; the cost of being Disabled and the probability of transitioning between Nondisabled and 
Disabled health states; and the cost of LTC and the probability of transitioning between Disabled 
and LTC. 
The Net Monetary Benefit (NMB) of each one-way and two-way sensitivity analysis was 
determined at a Willingness to Pay (WTP) threshold of $20,000 per QALY, which is a 
reasonably low value. In cost-effectiveness analysis the WTP threshold indicates the amount one 
is willing to pay to gain one QALY.  The NMB is calculated using the formula: NMB = 
WTP*ΔQALY-ΔCost. A NMB of >0 was considered to be a desirable outcome because the 
health gain is achieved at a cost that is less than the willingness to pay threshold.  
Probabilistic Sensitivity Analysis: In probabilistic sensitivity analysis, parameter values are 
drawn from probability distributions (Appendix 5). Beta distributions were used for utility values 
and transition probabilities. A log normal distribution was used for costs. In a probabilistic 
sensitivity analysis, a value is chosen randomly from each distribution. The QALYs and cost are 
then calculated based on these sampled values. This sampling process was competed 10,000 
times with 1,000 trials for the purposes of this model. 
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4.2.9 Other Model Considerations  
The model was projected for a total length of 35 years or until death (70 cycles of six months 
each). Costs and utilities were discounted at a rate of 3% per year (1.5% per six month cycle). A 
value of 3% was chosen to reflect the chronic nature of stroke disabilities. All analyses were 
conducted using TreeAge Pro 2013.  
44 
 
 
 
  
5 Integrated Article 
A version of this manuscript will be submitted to Stroke.  
 Introduction  
Over 50,000 Canadians experience a stroke annually, often leading to residual deficits that 
require months or even years of recovery.1  As such, stroke is the second major cause of long-
term disability in North America.2,3   It is estimated that over 50% of individuals who have 
experienced a stroke will have moderate to severe physical, cognitive, and psychosocial 
impairments, with these deficits often requiring intense rehabilitation throughout the acute, post-
acute, and chronic phases of recovery.4   
The costs of stroke to the Canadian economy are high. One estimate suggests that $3.6 billion per 
year are spent on both the direct and indirect costs of stroke in Canada.5 Although the majority of 
direct costs are spent on acute and inpatient care, a large sum is attributed to post-acute 
rehabilitation, stroke prevention, and physician visits for routine follow up and management of 
medical comorbidities such as depression, urinary tract infections, and pain.6 A recent systematic 
review found that an estimated 30-62% of individuals will be readmitted to hospital following 
post-acute care for all cause morbidity, and an additional 20% of stroke survivors will experience 
a recurrent stroke, resulting in considerable added cost to the health care system.1  
Substantial research has been performed on in-home rehabilitation programs after stroke.  A 
meta-analysis of studies comparing home-based and centre-based stroke rehabilitation facilities 
found that home-based services were associated with greater client satisfaction, reduced caregiver 
strain, lower readmission rates, and improvement in Activities of Daily Living (ADLs).7 Pooled 
analysis also demonstrated a significant increase in functional independence in the form of 
improved scores on the Barthel Index. Reviewers noted that home-based rehabilitation may be 
superior, in part, because individuals have the opportunity to immediately transfer skills they 
have learned in their own living environment.7   
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To date, few economic reviews have been completed examining the costs of home-based 
rehabilitation programs.  Most of these analyses compared the costs of home-based programs to 
hospital-based outpatient programs and found that home-based services were usually cost-
effective or no more costly than hospital-based programs, particularly in the context of early 
supported discharge from hospital.8 A systematic review of costs for home-based rehabilitation 
programs found that, overall, domiciliary rehabilitation reduced hospital stay by 13 days (95% 
CI: -19 to -7 days) and, in combination with early discharge from hospital, resulted in an overall 
mean cost reduction of 15% compared to in-hospital rehabilitation without any compromise to 
patient outcomes.9 However, there are mixed results when examining the effectiveness of 
community-based programs in terms of patient outcomes and cost.10 There is a great deal of 
heterogeneity in the studies performed to date. Variation in programs, such as the professional 
makeup of the interdisciplinary teams, as well as differences in the health care systems in which 
they operate, make it difficult to generalize results to other populations. Consequently, 
extrapolation of results to a Canadian setting is difficult.   
In Ontario, Canada’s most populous province, the availability of post-acute rehabilitation is 
limited.  In 2014, over 35% of stroke patients, including 40% of acute patients, were discharged 
home with no further rehabilitation services.11 This rate may be as high as >50% in more rural 
areas.46 Research has shown that less than 10% of stroke patients will make a full recovery, with 
the remaining requiring ongoing rehabilitation.1 Furthermore, 25% of stroke sufferers are left 
with minor disability, and 40% with major disability, requiring therapy.1 These numbers suggest 
a system where a large subset of patients with stroke receive little or no rehabilitation after they 
leave the hospital. In many cases, further rehabilitation is not accessible due to issues of mobility, 
transportation, or geographical limitations in rural and remote areas. In many other instances, 
these services are not available at all or available in very limited capacity. Home-based 
rehabilitation aims to help fill this service gap.  
The Community Stroke Rehabilitation Teams (CSRT) are home-based rehabilitation teams which 
provide service to eight counties in Southwestern Ontario. They aim to provide care to adult 
stroke survivors living in their homes who are otherwise unable to access traditional outpatient 
rehabilitation services due to lack of accessibility or availability of services.  The CSRTs deliver 
services individualized to each client based on the Canadian best-practice recommendations for 
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stroke.  This may involve physical rehabilitation, social and emotional support, education, system 
navigation, community re-integration, and caregiver support.12 Provision of these services is 
based on an interdisciplinary model with involvement of a registered nurse, occupational 
therapist, physiotherapist, speech-language pathologist, social worker, therapeutic recreation 
therapist, or rehabilitation therapist working together as necessary. Since implementation in 2009 
the program has provided active services to over 3000 clients. 
The purpose of this study was to perform a 1-year prospective evaluation of utility outcomes and 
costs among clients of the Community Stroke Rehabilitation Teams. A Markov model was 
developed to compare the long-term cost-effectiveness of this community-based stroke 
rehabilitation team model to no formal rehabilitative care for patients recovering from stroke. 
 
 Methods 
Patients admitted to the CSRT program consist of adult stroke survivors with specific and 
achievable rehabilitation goals who are motivated and able to participate in the program, and 
whose needs are best met by specialized stroke rehabilitation services in the community. 
Consecutive patients admitted to the CSRT program between January 2012 and February 2013 
were approached by CSRT staff at their initial home visit, given a brief description of the study, 
and asked for written consent to provide their name and contact information to a member of the 
research team.  
As soon as possible, contact with the client or appropriate proxy was made via telephone to 
explain the study in detail and obtain verbal consent for participation.  Proxy respondents were 
only accepted if the individual lived with, or had regular day-to-day contact with, the participant. 
Baseline assessments were completed over the phone and involved collection of patient 
information and initial assessment of the EuroQol 5D 5L (EQ-5D-5L)13-15 (Appendix 6) and 
Stroke Impact Scale (SIS) (Appendix 7).16-20  Follow up phone calls were performed six and 12 
months after baseline assessment. During follow-up telephone interviews, participants were 
reassessed using the EQ-5D-5L and SIS, and were also administered the Health and Social 
Services Utilization Survey (HSSUS) (Appendix 8),21 which consists of a range of questions 
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designed to capture the types and quantities of health and social services accessed by patients. 
Respondents were asked to provide healthcare utilization information for the first six months and 
the 6-12 month period after the baseline call separately.  
Ethics approval was obtained from the research ethics board at Western University (Appendix 9). 
Economic Model and Analysis 
A Markov Model was developed to project the long-term costs and impacts of this program 
(Figure 5.1). In this model, CSRT was compared with controls who were assumed to have 
received no, or limited, further rehabilitation services. The model consists of four possible health 
states: Nondisabled (able to live independently, completely independent in activities of daily 
living), Disabled (live in one’s own home, requires assistance for activities of daily living), Long 
Term Care (resides in a Long Term Care or assisted living facility), or Death.  The model time 
horizon we used was 35 years or until death, with six month stages. A societal perspective was 
taken, however, the costs of loss productivity and leisure time were not accounted for.22 
 
 
 
 
 
 
 
Because of the unique nature of the Community Stroke Rehabilitation Team program, as well as 
the context in which it operates, it was necessary to draw on a number of sources to populate the 
parameters of our Markov Model. As the Community Stroke Rehabilitation Team Economic 
Study was single-armed, it was necessary to find information on health outcomes and utilities for 
a comparator population.  As such, we relied mainly on large population based studies. 
Additionally, the one-year time frame of the CSRT Economic Study was not sufficient to provide 
long-term data to inform the cost-effectiveness of the program. Thus, the combination of primary 
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Figure 5.1: Decision tree and Markov model 
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and literature based sources also allowed us to create a long-term projection model. A summary 
of these sources by study time frame is presented in Table 5.1. 
Four main sources were used to populate the parameters of the model:  
1: Community Stroke Rehabilitation Team Economic Evaluation Study Data (N= 212) 
2. Markle-Reid et al. (2011) 23: Individual patient data were used in the present analysis. 
The control group (N= 49) in this study received limited rehabilitation following hospital 
discharge, and thus was the focus of all analyses using this data.  
3: Canadian Community Health Survey (2010)24: The Canadian Community Health 
Survey (CCHS) was a cross sectional study of the Canadian population. Individual level 
data is accessible in freely available datasets. Only data from individuals replying ‘yes’ to 
the question ‘Do you suffer from the effects of a stroke?’ (CCC_151) were included in the 
analysis (N= 993).  
4. Literature Based Sources: 
1. Magalhaes et al. (2014)25 (N= 380) 
2. Oxford Vascular Study26,27 (N= 748 with stroke) 
3. Perth Community Stroke Study28 (N= 328) 
4. Ontario Based study of LTC Residents29,30 (N= 8,058) 
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Table 5.1: Parameter data sources by timeframe 
 
Health State Definitions 
Both the CSRT study and study by Markle-Reid et al.23 administered the SIS or SIS-16 to 
participants. For CSRT participants, a SIS-16 score was derived from the full SIS. This measure 
has been found to discriminate well amongst disability levels on the modified Rankin Scale17,31 
Parameter  
Baseline – 12 month 
follow-up 
12 months + 
Long-term 
projection 
Utilities 
CSRT 
(Disabled/ 
Non) 
 
Community Stroke 
Rehabilitation Team 
Economic Study 
Oxford 
Vascular Study 
 
Canadian 
Community 
Health Survey 
(2010) 
 
Comparator 
(Disabled/ 
Non) 
 
Oxford Vascular Study 
trend (using CSRT study 
baseline value) 
LTC Ontario based study of LTC residents 
Costs 
CSRT 
(Disabled/ 
Non) 
 
Community Stroke 
Rehabilitation Team 
Economic Study 
 
Canadian Community Health 
Survey (2010) 
 
Comparator 
(Disabled/ 
Non) 
 
Markle-Reid et al.23 
LTC Ontario based study of LTC residents 
Transition 
Probabilities 
Between 
Disabled and 
Nondisabled 
CSRT: Community Stroke 
Rehabilitation Team 
Economic Study 
Control Group: Markle-
Reid et al. (2011) 
 
Perth Community Stroke Study 
Disabled and 
Nondisabled 
to LTC 
Oxford  Vascular  Study 
Disabled and 
Nondisabled 
to Death 
Magalhaes et al. (2014) 
Ontario based study of LTC residents 
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and, as such, was used to differentiate between Disabled and Non-Disabled health states. A score 
of <75 on the SIS-16 was considered to be Disabled, and ≥75 Non-Disabled. These cut-offs are 
consistent with definitions of disabled and non-disabled found throughout the stroke literature 
including those used in our literature based sources.25-27  
The CCHS asks a number of questions relating to physical functioning and restriction of 
activities. For the variable ‘Participation and Activity Limitation’ (RACDPAL), a classification 
of ‘never’ was considered to be a Non-Disabled individual, and a mean of the ‘sometimes’ and 
‘often’ classifications were considered to be Disabled.  
Cost Inputs 
Costing of health services employed the ingredients approach in which the frequency of 
utilization of health services was multiplied by the price.  
Health care usage costs for the Community Stroke Rehabilitation team and No Therapy arm, 
using individual level data from Markle Reid et al.23 were derived from responses to the Health 
and Social Services Utilization Survey (HSSUS). Costs included physician visits (including 
Emergency Room visits and specialists), other health care professionals/ services, 
hospitalizations and surgeries, diagnostic tests and laboratory expenses, devices and special 
treatments, household help, and travel costs. Cost estimates are based on the Ontario Health 
Insurance Plan (OHIP) schedule of benefits and fees, and were inflated to 2013 Canadian Dollars 
using the Ontario health and personal care consumer price index inflation rates.32 Costs of out of 
pocket and device expenses were determined using internet based sources for the price and 
participant self-report.  
Visit costs for the CSRT program were provided by the program. Each visit cost included a 
proportion of program overhead, therapist cost, as well as any associated therapist travel costs. 
Per visit cost calculations were specific to therapist type. Because of the delay in contact between 
the initiation of CSRT services and baseline contact, as well as possible client recall bias, the 
number of visits a client had with CSRT care providers was derived from administrative data.  
For the long term projection of costs, questions pertaining to health care utilization in the CCHS 
were isolated, and a cost per visit was applied based on costing data used in the CSRT study. 
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Information on travel expenses, household help, and the cost of devices were not available. As 
such, the mean of all household help, travel expenses, and device costs from both CSRT data and 
the Markle Reid et al.23 study were added to each estimate.  
Mean weekly costs of Long Term Care (nursing/ personal care, physician costs, other), 
hospitalizations, emergency department visits, and diagnostic tests were totaled and a six month 
cost estimated from the weekly cost reported in an Ontario based study of LTC residents.30,33 
LTC costs were the same in both the CSRT and comparator arm for the duration of the model. 
Transition Probabilities 
Based on health state definitions, the proportion of individuals in each health state (Disabled and 
Nondisabled) and transitioning between health states between baseline and six month follow up, 
and six and 12 month follow ups was determined from the CSRT study data and No Therapy 
cohort using Markle-Reid et al.23 study data.  
We estimated the annual probability of death from Magalhaes et al. 25 and admission to Long 
Term Care from the Oxford Vascular Study26 by converting cumulative survival to time t, to a 
per cycle rate using the formula r= ln(-S(t)/t), where r is the per cycle rate, S(t) is the cumulative 
probability, and t is the number of cycles. We then converted the per cycle rate to a per cycle 
probability using the formula p = 1 – exp(-r*t), where p is the per cycle probability, r is the per 
cycle rate, and t is the number of cycles. Data were extrapolated beyond the study period using 
regression analysis to estimate the trend in survival.  
Similarly, from a 10 year cumulative probability of new disability in the Perth Community Stroke 
Study,28 a per cycle rate was calculated. Research on outcomes following stroke almost 
exclusively demonstrate functional decline as time post stroke onset increases.88,92 Therefore, it 
was assumed that after one year, individuals would no longer improve disability levels (i.e. move 
from the Disabled to Nondisabled health state). 
Death in LTC was determined using unpublished data from Hillmer (2008) of the six month 
cumulative incidence of mortality in LTC residents.30  
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Utilities  
CSRT study participant responses to the EQ-5D-5L were used to generate index based values. 
Mean utility values for each health state were calculated for each time point. For the No Therapy 
control arm, data from the Oxford Vascular Study were used to calculate a trend in health utilities 
over a 5 year period for both Disabled and Non-Disabled health states. This trend was then 
applied to the mean baseline CSRT utility for both Disabled and Non-Disabled in six month 
intervals and projected to the end of the study data. This trend was applied to CSRT study data 
following the first 12 months of the model. Following the first 10 cycles of the model, health 
utility indexes by five year age range were derived from CCHS data. Mean utility values for all 
individuals in LTC were derived from the Ontario based study of LTC residents29 and applied to 
the duration of the model. 
Analysis  
A cost-utility analysis was completed to determine the incremental cost of the CSRT program per 
Quality Adjusted Life Year (QALY) gained when compared to No Therapy using Expected 
Value (EV) calculations. The total EV of cost and accumulated QALYs were estimated for each 
cohort.  
Scenario analyses were completed to assess the impact of transitioning from a Disabled to 
Nondisabled health state in the CSRT cohort. This was completed by setting all transition values 
equal to the No Therapy values and conducting an EV calculation. Scenario analyses were also 
completed on discount rates by examining expected value calculations at 0, 3, and 5% 
discounting values.  
To assess uncertainty in the model, one-way sensitivity analysis was completed on all 
parameters. Reasonable input ranges were determine from 95% confidence intervals for costs, 
utilities and transition probabilities. Threshold analyses were conducted on all sensitive 
parameters to determine the exact value at which the two cohorts were equal.  
Two-way sensitivity analyses were conducted on key model parameters: the cost of being 
Disabled and the probability of transitioning between the Disabled and Nondisabled health states; 
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the cost of being Disabled and the probability of transitioning between Nondisabled and Disabled 
health states; and the cost of LTC and the probability of transitioning between Disabled and LTC. 
The Net Monetary Benefit (NMB) of each one-way and two-way sensitivity analysis was 
determined at a Willingness to Pay (WTP) threshold of $20,000 per QALY. In cost-effectiveness 
analysis the WTP threshold indicates the amount one is willing to pay to gain one QALY.  The 
NMB is calculated using the formula: NMB = WTP*ΔQALY-ΔCost. A NMB of >0 was 
considered to be a desirable outcome.  
A Probabilistic Sensitivity Analysis (PSA) was conducted to assess uncertainty in model 
parameters. Beta distributions were used for utility values and transition probabilities and Log 
Normal distributions for costs. In a probabilistic sensitivity analysis, a value is chosen randomly 
from each distribution. The expected value of the QALYs and cost are then calculated based on 
these sampled values. This sampling process was competed 10,000 times with 1,000 stochastic 
trials for each set of randomly drawn parameters.  
Costs and utilities after the first year were discounted at a rate of 3% per year. A value of 3% was 
chosen to reflect the chronic nature of stroke disabilities. All analyses were conducted using 
TreeAge Pro 2013.  
 
 Results 
A total of 212 CSRT participants were recruited between January 2012 and February 2013. 
Demographic information for CSRT participants at baseline is provided in Table 5.2.  
Overall, clients in the CSRT program had fewer costs in the first two cycles of the model (first 12 
months) when compared with No Therapy controls. Although Nondisabled individuals in the 
CSRT cohort had higher health utilities than No Therapy, this was not the case for Disabled 
individuals. This carried through for the first 10 cycles of the model following the trend observed 
in the Oxford Vascular Study27, after which utility values in both cohorts were equal. During the 
first two cycles of the model, more individuals in the CSRT cohort improved, transitioning into 
the Nondisabled health state. Following the first two cycles of the model, all costs and transition 
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probabilities were the same for both CSRT and No Therapy cohorts. All parameter values used in 
the model can be found in Appendix 3. 
Table 5.2: Baseline characteristics of CSRT participants 
 n= 164 
Demographics  
Age - years (SD)  66.2 (12.6) 
Number of Males (%) 94 (59.1%) 
Place of Residence (%)  
House/Apartment 148 (90.2%) 
Seniors Apartment 6 (3.7%) 
Relative’s House 3 (1.8%) 
Lives with family member or other support person 139 (87.4%) 
Family or other support available on a daily basis 124 (78.0%) 
Stroke Event and History  
Able to stand up and walk around on own after stroke (%) 82 (50%) 
Days Since Stroke (Mean, SD) 62 (17) 
Recurrent Event (%)  
Stroke 27 (17.0%) 
Transient Ischemic Attack 4 (2.5%) 
Stroke Risk Factors  
Diagnosed with Diabetes 50 (31.4%) 
Diagnosed with High Blood Pressure  112 (70.4%) 
Diagnosed with Heart Disease 36 (22.6%) 
Diagnosed with High Cholesterol  82 (50.3%) 
In an Expected Value calculation, the CSRT program cost $212,311 per 11.10 QALYs 
($19,127/QALY) and No Further Therapy cost $233,826 per 10.02 QALYs ($23,277/QALY). 
This resulted in an incremental cost saving of $21,515 and incremental effect of 1.08 QALYs for 
the CSRT program when compared to No Therapy. At a WTP threshold of $20,000, CSRT had a 
Net Monetary Benefit of $43,115 when compared with the No Therapy. 
Scenario analyses revealed that for all scenarios the CSRT remained cost-effective when 
compared with No Therapy. Furthermore, the NMB remains >0 in all cases when compared with 
No Therapy. However, the cost per QALY exceeds $20,000 both when the CSRT probability of 
becoming Nondisabled is set equal to that of No Therapy, as well as when the discount rate is 
0%, becoming $20,809/QALY and $21,352/QALY, respectively.  
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In the one-way sensitivity analyses, NMB was assessed over the plausible ranges of values for all 
cost, utility and transition probabilities. Results of the one-way sensitivity and subsequent 
threshold analysis are presented in Table 5.3. Results were found to be sensitive to 9 parameters: 
Cost of CSRT Nondisabled and Disabled, Disabled Utility for both CSRT and No Therapy, 
transitions of Nondisabled and Disabled to LTC, transition from Nondisabled to Disabled in both 
cohorts, and Disabled to Nondisabled in the No Therapy cohort.  
Table 5.3: Results of one-way sensitivity analysis and threshold analysis 
Parameter  
Parameter 
Value 
(Base case) 
Range (min, max) 
Sensitive 
(Y/N) 
Parameter 
Value at 
Threshold  
(NMB < 0) 
 
Cost 
CSRT Nondisabled $4,769 $52, $23,775 Y $9,567 
CSRT Disabled $9852 $43, $41,856 Y $10,764 
No Therapy Nondisabled $9,032 $52, $23,775 N - 
No Therapy Disabled $10,761 $43, $41,856 N - 
LTC $29,905 $14,547, $43, 643 N - 
 
Utility 
CSRT Nondisabled 0.79 0.52, 1.0 N - 
CSRT Disabled 0.56 0.13, 0.94 Y 0.22 
No Therapy Nondisabled 0.79 0.51, 1.0 N - 
No Therapy Disabled 0.65 0.22, 1.0 Y 0.87 
LTC 0.36 0.03, 0.69 N - 
Transition 
Probabilities 
Nondisabled to Death 0.017 0.0, 0.27 N - 
Disabled to Death 0.03 0.0, 0.36 N - 
Nondisabled to LTC 0.01 0.0, 0.21 Y 0.08 
Disabled to LTC 0.05 0.0, 0.48 Y 0.012 
LTC to Death 0.07 0.0, 0.57 N - 
CSRT Nondisabled to 
Disabled 
0.052 0.0, 0.44 Y 0.18 
CSRT Disabled to 
Nondisabled 
0.12 0.0, 0.61 N - 
No Therapy Nondisabled to 
Disabled 
0.18 0.0, 0.90 Y 0.13 
No Therapy Disabled to 
Nondisabled 
0.06 0.0, 0.41 Y 0.10 
*Range is 95% Confidence Interval 
Notes: Y, Yes; N, No; NMB, Net Monetary Benefit; LTC, Long Term Care  
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Two-way analyses (Table 5.4) revealed that the CSRT program has a NMB >0 in the majority of 
instances. This is not the case only when parameter values are at the minimum range value of 
transition probability and the maximum cost for CSRT Disabled to Nondisabled and costs of 
Nondisabled.  
Table 5.4: Results of two-way sensitivity analysis 
Net Monetary Benefit Min Max 
Cost LTC 
Disabled to LTC 
Min $211 -$10,614 
Max $36,241 $66,185 
 CSRT Cost Nondisabled 
CSRT Disabled to Nondisabled  
Min $31,302 -$19,150 
Max $19,238 $1,753 
 CSRT Cost Disabled 
CSRT Disabled to Nondisabled  
Min $20,830 $52,444 
Max $14,906 $34,426 
 
In the Probabilistic Sensitivity Analysis, the mean cost of CSRT was $212,012 (SD $6,657), and 
the mean utility was 11.08 (SD 0.22). The mean costs of No Therapy was $233,347 (SD $7,436) 
and mean utility 10.02 (SD 0.20). The NMB of the CSRT cohort was $9,558 (SD $6,688), 
whereas the No Therapy cohort had a negative NMB at -$33,149 (SD $6,855). The incremental 
NMB of CSRT compared to No Therapy was $42,535 (SD $9,578)). Results of the PSA are 
presented as an incremental cost-effectiveness scatterplot (Figure 5.2). The PSA revealed that 
Incremental Cost Effectiveness (ICE) of the CSRT program is superior in 100% of iterations 
when compared to No Further Therapy.  
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Figure 5.2: Incremental cost-effectiveness scatterplot 
 
 Discussion  
Results of this analysis indicate that the CSRTs are a cost-effective model for providing home-
based rehabilitation following stroke. The program was found to be both less costly (incremental 
cost = -$21,515) and more effective (incremental effect = 1.08), resulting in a NMB of $43,115 
for the CSRT program compared with No Therapy. Furthermore, results of the Probabilistic 
Sensitivity Analysis indicate that the CSRT program is always cost-effective when compared to 
No Therapy at a WTP threshold of $20,000/ QALY. One-way and two-way sensitivity analyses 
showed that the NMB of the CSRT program is >0 in the majority of instances across a range of 
values.  
Results of the one-way sensitivity analysis indicate that there are several instances in which the 
results were sensitive; however, upon examination of threshold values, it can be observed that 
while the threshold values fall within the plausible range as defined by the 95% confidence 
interval, they may not always be plausible estimates of the mean value. For example, in the case 
of the Disabled utilities for both CSRT and No Therapy, the threshold values would provide low 
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and high estimates of the mean utility, respectively (0.22 and 0.87). Additionally, sensitivity 
analysis on transition probabilities revealed threshold values that would likely not be rational or 
sustainable given the time horizon of the model. The wide range of values is due, in part, to large 
95% confidence intervals resulting from small sample sizes in our study data. Some threshold 
values were realistic estimates of the mean (for example, costs for CSRT Disabled and 
Nondisabled). This suggests that the result is sensitive to the cost of the CSRT intervention.  
The model results were driven by the greater proportion of CSRT individuals improving in 
function during the first two cycles of the model, resulting in a greater proportion of Nondisabled 
individuals in the CSRT cohort. The Nondisabled health state had a higher utility, lower cost, and 
lower probability of entering LTC than those in the Disabled health state. Individuals in the 
CSRT program also had lower costs than the No Therapy comparator for both Disabled and 
Nondisabled health states for the first two cycles of the model. This may be a result of the ability 
of the CSRT program to address stroke related concerns and facilitate referrals to other health 
professionals and services, reducing the number of additional health care visits, although this 
observation was not assessed in this analysis.  
As in many modelling studies, a number of sources were used to populate the parameters of this 
analysis. In general, populations were comparable across studies, however, study heterogeneity 
precluded the ability to closely compare participants. Additionally, as the studies included were 
conducted in various countries, differences also existed between health care contexts; however, 
Canadian based data were used for all costs, an important consideration given the unique nature 
of our health care system.  
Economic studies comparing home-based stroke rehabilitation to a control group receiving no 
therapy are almost nonexistent. Furthermore, cost studies of home-based rehabilitation do not 
examine cost-effectiveness in terms of a cost/ QALY.  A meta-analysis of economic studies of 
adult rehabilitation by Brusco et al.34 found few cost-utility and cost-effectiveness analyses of 
rehabilitation programs, with the majority having a cost-minimization focus. Of programs 
examining stroke, six out of 11 cost studies were classified as cost-effectiveness or cost-utility 
analyses, although none presented results in the form of a cost per QALY or reported a WTP 
threshold. In general, studies examining home-based rehabilitation have demonstrated 
improvements in function35-41 and quality of life9,35,37,38 consistent with the findings in this study.  
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Although comparative studies of home-based stroke rehabilitation do not exist, the Willingness to 
Pay threshold used in this analysis ($20,000) can be considered conservative. WTP thresholds for 
stroke related therapies have been set at $50,000-100,000/ QALY.42-45 Therefore, at any WTP 
higher than $20,000/ QALY, the NMB of the program will only increase. This may also have 
implications for greater generalizability to countries around the world with varying economic 
environments and health care systems.  
The results of this study are important to consider when evaluating options to deliver stroke 
rehabilitation services to any areas where access to rehabilitation is a concern for many. As our 
analysis suggests that the program is cost-saving compared with not providing any therapy, areas 
without services should consider implementing such a program. This could have huge impacts on 
the health care system as a whole as survival from stroke is becoming more prevalent, and many 
survivors have ongoing rehabilitation needs. Assessments should be conducted on similar 
programs in other settings to further evaluate the cost-effectiveness of such models of care. 
Furthermore, this type of service delivery may have applicability to other subsets of individuals 
needing rehabilitation, such as geriatric, Acquired Brain Injury, and post-surgical rehabilitation.   
Limitations  
There were several limitations to the present analysis. Although common in modelling studies, 
the use of multiple data sources limited this analysis somewhat. The lifetime horizon of the 
model required the extrapolation beyond the available study data in many cases. Additionally, a 
lack of congruent study timelines meant there was also a need to interpolate at times. This meant 
a number of assumptions needed to be made. However, these assumptions were justified and well 
considered. Finally, it is largely unknown how reasonable our study results are as there is no 
current literature to compare to; however, the trends and general outcome observed are consistent 
with effectiveness studies of home-based stroke rehabilitation.  
Conclusions 
The results of this analysis suggest that Community Stroke Rehabilitation Team model of care is 
cost-effective when compared to a No Therapy alternative. Individuals in this program are better 
able to improve functionally, leading to better health related quality of life, and to use fewer 
health care resources resulting in further cost savings. Although particularly applicable to the 
60 
 
 
 
Canadian context, these findings may have widespread applicability to areas around with 
underserved stroke populations. 
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Chapter 6 
6 Discussion & Conclusions 
Results of this analysis indicate that the CSRTs are both less costly and more effective than a No 
Therapy cohort, and have a positive NMB of $43,115 when compared with No Therapy. 
Probabilistic Sensitivity Analysis results indicate that, at a WTP threshold of $20,000/QALY, the 
CSRT program is always superior to No Therapy. Furthermore, one and two-way sensitivity 
analyses indicate that in the majority of cases, the NMB of the CSRT program is greater than that 
of No Therapy, even at the minimum and maximum of the reasonable range of values.  
Results of the one-way sensitivity analysis showed that there are nine instances in which results 
were sensitive. Upon further examination of threshold values for which the CSRT program no 
longer has a NMB>0, it can be observed that some of these values are not necessarily reasonable. 
This is particularly true when considering that the one-way sensitivity analysis does not take into 
account time dependencies, due to limitations in the software used to implement the model. This 
is of particular concern in a long-term model with an aging population. This may be the case for 
CSRT and No Therapy Disabled utility value thresholds, for which values are unreasonably low, 
and high, respectively. For the CSRT Disabled utility, a value of 0.22 is quite small and is, in 
fact, much lower than the mean utility of LTC. Conversely, the threshold value for the No 
therapy Disabled utility is 0.87, which is much higher than mean value of the higher Nondisabled 
health state.  Several of the sensitive transition probability values may also be considered 
unreasonable. The threshold value of the transition probability of Nondisabled to LTC appears to 
be excessively high, being eight times that of the point estimate. This is also true for CSRT 
Nondisabled to Disabled transition, for which the threshold value is over 2.5 times that of the 
long-term projection transition probability estimate. These irrational threshold values may be 
attributed to small sample sizes in some data sources and, in turn, large 95% confidence intervals 
that were used to inform our reasonable range values.  
Several sensitivity analysis thresholds are more rational and should be more carefully considered. 
Variations in the costs of the CSRT program for both Nondisabled and Disabled health states 
indicate a NMB<0 at values higher than the point estimates used. However, these threshold 
numbers are not outside the realm of what may be considered reasonable. Similarly, transition 
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probability thresholds for Disabled to LTC, and No Therapy Nondisabled to Disabled and 
Disabled to Nondisabled are within realistic limits. However, when considering the longitudinal 
nature of the model and the aging nature of the study population, the sustainability of these 
threshold values over time is less plausible.  
Although there are several parameters to which the model is sensitive, the cost/ QALY remains 
below common WTP thresholds. A pessimistic scenario analysis, in which the benefit of CSRT 
was restricted to preventing further declines in disability, rather than improving disability levels 
was still associated with a cost per QALY of $20,809/QALY, which is well below commonly 
accepted thresholds. As such, the CSRT program would still be an attractive option even if its 
benefits were assumed to be more modest. Furthermore, the inability of the one-way sensitivity 
analysis to incorporate the time dependency of variables suggests that the PSA is a better 
characterization of parameter uncertainty as the software allowed for incorporating time 
dependent distributions. 
The transition between Disabled and Nondisabled health states during the first two cycles of the 
model, that is, during CSRT services, shows an influence on the long-term projection. These are 
the only two cycles in which transition probabilities differ between the CSRT and No Therapy 
cohorts. During this time period, a greater number of CSRT individuals are improving 
functionally, thereby leaving the Disabled health state and entering Nondisabled, resulting in a 
higher proportion of individuals in the Nondisabled health state in the CSRT cohort than in the 
No Therapy cohort. This has long-term impacts as these individuals have a higher utility, are less 
costly, and are less likely to enter LTC. This is also observed in the one-way SA as the transition 
probability of moving from Disabled to Nondisabled in the No Therapy cohort approaches the 
maximum value of the reasonable range. As observed in the one-way SA, keeping people out of 
LTC has an enormous impact on long-term cost-effectiveness. This suggests that therapy 
provided to CSRT clients allows them to improve in their health status and has subsequent long-
term impacts on the overall costs and QALYs gained in these individuals.   
Because the CSRT program improves the health state of more individuals early on, a scenario 
analysis was completed to assess the extent of this benefit on the overall model. When this 
benefit is removed from the model, and Disabled CSRT individuals are given the same 
probability of transitioning to Nondisabled as the No Therapy cohort, the CSRT program remains 
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cost-effective compared to No Therapy; however, the cost/ QALY exceeds the WTP value of 
$20,000. However, as noted previously, the cost per QALY remains below commonly accepted 
thresholds. 
Additional efficiencies of the CSRTs are observed during the first 12 months of the program 
which may contribute to its long-term cost-effectiveness. Mean cost values in the CSRT cohort 
were lower than that of the No Therapy group for both Disabled and Nondisabled individuals, 
even when program costs were included, for the first two cycles of the model. This is somewhat 
counterintuitive as one would expect that these mean costs would be higher given the cost of the 
program itself. It appears that CSRT clients may use fewer health care resources. This may, in 
part, be due to the ability of the CSRT to address stroke related health concerns, thereby reducing 
the need for additional health care visits, as well as facilitating referrals to health care providers 
when necessary. This consolidation of services offers the potential for overall health care cost 
savings. In addition to lower costs, Nondisabled individuals also experience higher health utilities 
than the No Therapy cohort, contributing to the program’s cost-effectiveness. Conversely, 
Disabled individuals have lower health utilities. The increased potential for CSRT individuals to 
improve in health status, in combination with the cost and health utility benefits of this program, 
which are observed during the first two cycles of the model only, has a significant long-term 
impact on the cost-effectiveness of this program over a No Therapy comparator.  
As is the case in modelling, the reliability and validity of the model is of importance. Debugging 
of the model was completed to appraise its internal validity and to ensure that there were no 
programming errors or inefficiencies in the model structure. The extent of model and parameter 
uncertainty were also evaluated using several types of sensitivity analysis. Although results were 
generally not sensitive to variation of parameter values, the time dependency of many of the 
variables may have not been taken into account in the one and two-way sensitivity analysis. This 
will likely have led to inflated costs and utility values in these analyses. The time dependency of 
many of the variables, however, was accounted for in the expected value calculations, as well as 
the PSA through the incorporation of time dependent distributions in many cases.  
Although we strove to conduct the most rigorous analysis possible, as in many studies, there were 
limitations. Although common in many modelling studies, the use of multiple data sources 
limited this analysis somewhat. Prominently, the linking of CSRT and No Therapy effectiveness 
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variables of was of particular challenge. As such, inconsistencies in sensitivity analysis may have 
been possible, with CSRT values selected from parameter distributions being low relative to No 
Therapy values. This could have been avoided through the use of relative risk estimates as 
opposed to means as point estimates, however, relative risk values are difficult to determine with 
multiple, somewhat heterogeneous, data sources. Additionally, the impact of specific events, such 
as hospitalizations and severe illnesses, were not considered. These events may have an influence 
on health outcomes and costs that would be important to consider in a model. One additional 
limitation was the lifetime horizon of the model and a lack of long-term data to inform such a 
projection. Of data included in this analysis, the longest study timeline was 10 years. This 
required us to extrapolate beyond study data for all parameters. Although care was taken to use 
the most appropriate methods, the understudied lifetime natural history of stroke, in combination 
with an aging cohort, resulted in uncertainty about the accuracy of the estimates. 
Although we strove to find the most appropriate sources to inform this model, discrepancies 
between study populations were present to some degree. Although our comparator cohort is 
labeled ‘No Therapy’, in truth it was largely unknown how much rehabilitation individuals in 
these studies received. Because many were large population based studies, it is reasonable to 
assume that some of these individuals did, in fact, receive post stroke rehabilitation; however, the 
amount and intensity of this therapy likely varied widely. Furthermore, during the first 12 months 
(2 cycles) of the model, the time during which stroke rehabilitation is most likely to be of 
benefit,93 model parameters for both CSRT and No Therapy were largely informed by individual 
level study data, for which amount of and type of therapy received was known. Participant 
demographics also varied between study populations with the mean age of populations ranging 
from 70.626-75.086,87 years of age. This is slightly older than the CSRT sample, which had a mean 
age of 66.2 years. Age has been demonstrated to impact one’s ability to functionally recover from 
stroke,94 however, it is unknown to what degree this may have affected the results. The ratio of 
males to females also differed, with the proportion male ranging between 44.785-61.5%26.  The 
proportion of the CSRT study sample who were male fell within this range at 59.1%. Other 
characteristics that may have an effect on recovery from stroke such as medical comorbidities, 
number of recurrent stoke events, and stroke type and severity, were more difficult to compare 
between study populations. 
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The context in which these studies were conducted compared to the setting in which the CSRTs 
operate is also important to consider. All cost data used in this analysis were Canadian based, an 
important consideration given the unique nature of our economy and health care system. 
Furthermore, No Therapy comparator costs for the first 12 months of the study were determined 
using individual level, and Ontario based, data from a cohort similar to the CSRTs, but with 
limited rehabilitation access. Additionally, the same health service utilization survey was used for 
both this study and the CSRT study. These consistencies were important in maintaining 
methodological rigor in this analysis. All LTC parameters were also derived from an Ontario 
based study. Although studies used in the long-term projection were conducted in countries other 
than Canada, they all have a similarly high standard of health care and quality of living,95 
however, access to health care services may differ between these countries and Canada due to the 
unique geographic nature of our country.  
Study characteristics of the literature based sources included in this analysis should also be 
considered. Consistency in outcome measures used to determine costs, utilities, and transition 
probabilities differed to some degree. To measure utility, the EQ-5D was used for the first 10 
cycles of the model for both cohorts. However, for the long-term projection, utility values derived 
from the Health Utilities Index were used. Although these measures differ, model cycles during 
which they were applied were consistent between cohorts. Health state definitions did differ 
between primary data sources and literature based data sources as primary data sources used the 
SIS-16 and literature based the modified Rankin Scale (mRS); however, studies have found a 
good ability of the SIS-16 to discriminate between disability levels of the mRS.51,52 Furthermore, 
transition probabilities for the first 12 months of the model were determined using the SIS-16 for 
both cohorts. Health state definitions for CCHS data were a greater challenge, and so the most 
conceptually appropriate variable, self-reported disability, was used to distinguish between those 
who may be considered Disabled and Nondisabled; however, there was no literature on the 
validity of this measure. In addition to the need to use results from differing outcome measures, 
discrepancies between studies in follow up time points and study time lines required both 
interpolation and extrapolation of results to populate the model. 
The lifetime horizon of this model (35 years or until death) also poses some limitations. In 
particular, different measures used to determine health states over the life of the model may have 
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led to some misclassification in health states. This is of particular concern with data from the 
CCHS as selection of a health state classification was based on opinion and was not supported by 
the literature. However, measures used for health state classifications were consistent between 
CSRT and comparator arms for the entirety of the model, and so any misclassifications would 
have been the same between the two cohorts. Furthermore, this would have been assessed to 
some degree in the extensive sensitivity analysis. Extrapolation beyond the available study data 
also poses some concerns with the long time frame used in the model. However, the greatest 
impact to the final model results are observed during the first few cycles as previously discussed. 
The model also incorporates discounting of costs and utilities. Therefore, as the timeline of the 
model progresses, the costs and utilities incurred impact the results to a lesser degree. 
Furthermore, lifetime horizons are typical in modelling and are recommended by the Guidelines 
for the Economic Evaluation of Health Technologies: Canada81, particularly for chronic 
conditions such as stroke.  
The scope of this analysis was fairly broad, and so results may be of interest to a range of groups.  
Direct costs to the health care system were largely captured, in addition to a number of publically 
funded health care programs and services. Out of pocket expenses were also captured in the form 
of costs of devices, travel to appointments, and household help. This analysis did not capture lost 
productivity, and so cannot be considered a comprehensive societal perspective. Additionally, 
some health care costs may not have been captured including medication costs, as well as many 
publically and privately funded programs and health care providers in the long-term projection, 
as use of many of these services were not captured by the CCHS survey; however, we did attempt 
to account for some of these services and items by incorporating costs captured in the CSRT and 
Markle-Reid et al. 26 study data into CCHS cost means.   
The results of this analysis are difficult to compare to existing research. Although there are 
economic studies of similar home-based rehabilitation programs, none examine cost-
effectiveness nor do they examine long-term projections. Many of these studies offer results in 
terms of program costs or only consider health care costs incurred during time spent in the 
program.42,58,73,74 Furthermore, variations in health care systems add an additional layer of 
complexity, making direct comparisons difficult and often inappropriate. Existing studies, in 
many cases, compare home-based program costs with those of hospital based outpatient 
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programs, which is also not applicable to the CSRT program context. Furthermore, many of these 
comparisons to outpatient programs offer mixed results in terms of the cost saving potential of in-
home rehabilitation. One study, Markle-Reid et al.,26 did compare a home-based stroke 
rehabilitation program with a usual care cohort receiving limited therapy. In this case, there was 
no significant difference in costs between the two cohorts over the 12 month study period. This is 
an Ontario based study and, as such, should be considered when examining the results of the 
present analysis. Furthermore, individual level data from that study were used to inform our 
analysis. Although this study by Markle Reid et al.26 did not find significant differences between 
groups, 12 months costs in the usual care group were slightly lower than the intervention group. 
This is contradictory to our results in which health care costs were lower in the CSRT program 
cohort. However, the Markle-Redi et al.26 study did not examine cost differences between health 
states, nor was a long-term projection or cost-effectiveness analysis completed.  
In line with much of the research that has been completed on home-based stroke rehabilitation 
programs, the present study was able to demonstrate a benefit in terms of improved function34-
37,39,57,59 and quality of life34-36,42 in stroke survivors accessing such programs. A relatively large 
proportion of CSRT clients were able to improve in their physical function, as was demonstrated 
by 27% and 10% improving from being Disabled to Nondisabled during the first and second six 
months of the study period, respectively. Furthermore, the mean utility value in the Nondisabled 
health state is much higher than in the Disabled health state, suggesting an associated 
improvement in health related quality of life. These results are in concordance with much of the 
published literature on the benefits of continued rehabilitation following hospital discharge.  
Although cost-effectiveness studies on home-based stroke rehabilitation have not been published, 
evaluations of other forms of stroke therapies are more prevalent. The majority of these studies 
focus on the acute treatment of stroke patients such as Tissue Plasminogen Activator (tPA) and 
Thrombolysis. Many of these treatments are aimed at minimizing damage to the brain in the 
immediate event of a stroke. In the majority of these cases, a Willingness To Pay threshold of 
$50,000/ QALY was used.  In general, WTP values are between $50,000 and $100,000 for acute 
stroke treatments.89,96-100 Cost-effectiveness analyses of post stroke therapies are scarcer, and the 
majority are presented as cost minimization analyses.101 One study of an Early Supported 
Discharge program presented a WTP threshold of ₤30,000/ QALY (approximately $56,000 
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CAD), with most scenarios considered cost-effective at just over ₤20,000/ QALY (approximately 
$37,000 CAD).102 Additional studies of post stroke rehabilitation therapies demonstrated cost-
effectiveness at WTP thresholds of $50,000/ QALY.103,104  Although many of these studies were 
conducted outside of the Canadian context, these WTP thresholds suggest that our WTP 
threshold of $20,000/ QALY was likely quite conservative.  
The commonly used benchmarked WTP threshold of $50,000/ QALY is quite arbitrary.105 There 
is much debate as to its origins and applicability in today’s economic context.  Some argue that a 
reasonable WTP should be based on the context and availability of resources,105 and not a pre-
defined standard. The World Health Organization suggests that one to three times the Gross 
Domestic Product (GDP) per capita of a country may be considered as a reasonable WTP 
threshold, with a WTP of one time the GDP per capita being considered highly cost-effective.106  
The Canadian GDP per capita is approximately $47,000,107 thus a reasonable WTP range would 
be $47,000-141,000/ QALY. The CSRTs are cost-effective compared to No Therapy in 100% of 
iterations with a WTP of $20,000. By this standard, the CSRT program would be considered 
highly cost-effective.  
The results of the cost-effectiveness analysis should be taken into account when considering 
rehabilitation options, particularly in underserviced areas. The CSRT program is both more 
effective and less costly when compared with No Therapy, resulting in a positive NMB. 
Although there is a cost associated with the program delivery, it appears that the improvement in 
quality of life and over all physical functioning of individuals served by the program leads to an 
overall cost savings. Furthermore, this program is highly cost-effective at <$20,000/ QALY 
gained, a relatively low and conservative WTP threshold. This could have huge implications for 
the health care system given the increasing prevalence of stroke survivors, and resultantly, stroke 
related disabilities. Canada in particular has many underserved, rural, and remote areas given its 
vast geography. In the majority of cases, individuals living in these areas are either unable to 
access much needed additional rehabilitation services, or receive very limited therapies. Results 
of this analysis demonstrate the need to provide treatment to these individuals, both to improve 
their own quality of life, as well as leading to cost-savings for the health care system as a whole. 
This analysis has demonstrated that it is, in fact, more costly to not provide these stroke survivors 
with further rehabilitation on discharge from hospital than it is to provide them with services.  
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The results of this analysis are largely generalizable to other settings. Although the geographic 
context of South Western Ontario is well suited to this type of program with a large rural 
population, there are many areas across Canada and the world where access to rehabilitation 
services post stroke is a challenge for many. A home-based stroke rehabilitation program 
modelled after the CSRTs may be a feasible option in these areas. Although the results of this 
study are based on a variety of sources and a number of assumptions, we are confident that it is 
representative of what may have been observed in a real world setting.  
The CSRT program has been providing rehabilitation services to stroke survivors since 2009, and 
has improved the health related quality of life for many of them. Many of these individuals would 
otherwise be left without any rehabilitation services following discharge from hospital. The 
CSRT model of care is unique and has demonstrated lasting health and economic benefits by 
supporting the rehabilitation of stroke survivors in their own home as demonstrated in this 
analysis. The CSRT program is continuing to evolve to better provide services to their clients and 
further improve efficiencies in care delivery. The introduction of technologies, such as 
rehabilitation through video-communication, is currently being evaluated, and should help to 
improve the function, efficiency and, ultimately, cost-effectiveness of these teams. Ongoing 
evaluation of client outcomes should be conducted to ensure continued progress and to help 
inform the development of similar programs around Canada and the world.  
This model suggests that the CSRT program is cost-effective compared to No Further Therapy. 
Clients accessing the CSRT program appear to use fewer health care resources during the first 12 
months of service provision, incur less costs, and accumulate more QALYs over the long-term. 
Furthermore, we were able to demonstrate this cost-effectiveness while maintaining a 
conservative estimate of costs, utilities, and transition probabilities.  The Community Stroke 
Rehabilitation Team model of care is a feasible and effective method of rehabilitation service 
delivery post stroke. 
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Appendices  
Appendix 1: Participant Flow through CSRT Economic Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
212 CSRT Patients 
Referred 
15 Control Patients 
Referred 
10 Control Baseline 
Calls completed 
- Declined to participate (n=2) 
- Unable to contact (n=1) 
- Did not meet inclusion 
criteria (n=1) 
- Discharged to LTC (n=1) 
Total (n=5) 
164 CSRT Baseline 
Calls completed 
- Recruited after study end date (n=3) 
- Secondary Stroke/Discharged to LTC 
(n=1) 
- Did not have a stroke (n=3) 
- Passed away (n=2) 
- Unable to contact (n=6) 
- Declined to participate (n=30) 
- Unable to contact before February 2 8th, 
2013 (n=3) 
Total (n=48) 
 
 
108 CSRT 6 Month 
Calls completed 
- Did not have a stroke (n=2) 
- Declined to continue (n=11) 
- Number not in service (n=2) 
- Unable to contact (n=15) 
- Passed away (n=3) 
- Scheduled for after July 31st, 2013 
(n=12) 
- Unable to contact before July 31st, 2013 
(n=9) 
- Discharged from team (n=1) 
- Declined CSRT services (n=1) 
Total (n = 56) 
37 CSRT 12 Month 
Calls Completed 
- Declined to continue (n=3) 
- Unable to contact (n=1) 
- Unable to contact before July 31st, 
2013 (n=8) 
- Recurrent stroke (n=1) 
- Scheduled for after July 31st, 2013 
(n=58) 
Total (n=71) 
4 Control 6 Month 
Calls completed 
- Declined to continue (n=1) 
- Number not in service (n=2) 
- Unable to contact (n=1) 
- Scheduled for after July 31st, 
2013 (n=2) 
Total (n = 6) 
0 Control 12 Month 
Calls Completed 
- Unable to contact before 
July 31st, 2013 (n=4) 
Total (n=4) 
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Appendix 2: Breakdown of Costs for CSRT and No Therapy Cohorts (First two cycles) 
 CSRT No Therapy 
Category Cycle Nondisabled Disabled Nondisabled Disabled 
CSRT Program 
1 2264.69 4019.86 - - 
2 114.31 253.77 - - 
Primary Health Care 
1 339.47 423.73 763.96 434.27 
2 226.78 422.22 510.36 432.72 
Other Health Services 
1 743.44 2971.82 4138.17 6323.32 
2 383.65 2623.52 2135.49 5582.22 
Lab Tests 
1 222.56 307.93 605.27 338.44 
2 103.96 276.97 282.73 304.41 
Hospitalizations 
1 953.43 2532.49 4537.97 3034.73 
2 495.16 2075.56 2356.77 2487.19 
Devices 
1 475.18 402.27 99.83 405.32 
2 73.11 423.49 99.83 405.32 
Household Help 
1 125.55 171.64 40.45 51.56 
2 0 63.09 40.45 51.56 
Travel 
1 149.19 309.70 72.00 153.10 
2 97.24 245.29 72.00 153.10 
*All costs in 2013 CAD 
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Appendix 3: Parameter values used in Markov model 
Costs and Utility Parameter Values 
  Value 
Parameter Stage CSRT 
Nondisabled 
CSRT 
Disabled 
No Therapy 
Nondisabled 
No Therapy 
Disabled 
LTC 
 
Costs 
1 
2 
3 
4769.28 
1386.28 
3384.13* 
9852.14 
6106.95 
4,520.39* 
9032.62 
5784.32 
3384.13* 
10,761.92 
9733.23 
4,520.39* 
29,095.94 
 
 
 
 
Utility 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
15 
25 
0.83 
0.838 
0.818 
0.798 
0.7905 
0.7955 
0.8005 
0.8055 
0.8105 
0.8155 
0.804 
0.831 
0.763 
0.65 
0.545 
0.614 
0.589 
0.5735 
0.5535 
0.5465 
0.5395 
0.5465 
0.5395 
0.5895 
0.5715 
0.505 
0.8020 
0.7945 
0.7995 
0.8045 
0.8095 
0.8145 
0.8195 
0.8095 
0.8145 
0.8195 
0.804 
0.831 
0.763 
0.65 
0.737 
0.7395 
0.7145 
0.699 
0.692 
0.685 
0.679 
0.672 
0.665 
0.5895 
0.5715 
0.505 
0.36 
*Truncated at final value 
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Transition Probability Parameter Values 
Stage CSRT 
Nondisabled 
to Disabled 
CSRT 
Disabled to 
Nondisabled 
No Therapy 
Nondisabled 
to Disabled 
No Therapy 
Disabled to 
Nondisabled 
Nondisabled 
to Death 
Nondisabled 
to LTC 
Disabled 
to Death 
Disabled 
to LTC 
LTC 
to 
Death 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
0.083 
0 
0.073* 
0.27 
0.1 
0* 
0.2083 
0.227 
0.073* 
0.056 
0.056 
0* 
0.016 
0.016 
0.016 
0.017 
0.017 
0.017 
0.017 
0.017 
0.018 
0.018 
0.019 
0.010 
0.008 
0.007 
0.006 
0.006 
0.009 
0.011 
0.010 
0.009 
0.008 
0.011 
0.019 
0.020 
0.021 
0.022 
0.023 
0.024 
0.025 
0.026 
0.027 
0.028 
0.029 
0.155 
0.107 
0.083 
0.066 
0.057 
0.049 
0.052 
0.052 
0.051 
0.046 
0.046 
0.07* 
*Truncated at final value 
  
Appendix 4: Model parameters – One & two-way sensitivity analysis 
Parameter   
Point 
Estimate 
95% CI 
Cost 
CSRT 
Nondisabled $4769 $52, 23775 
Disabled  $9852 $43, 41856 
LTC $29,905 $14,547, $43,643 
No 
Therapy 
Nondisabled $9032 $52, 69037 
Disabled  $10,761 $43, 74757 
LTC $29,905 $14,547, $43,643 
Utilities 
CSRT 
Nondisabled 0.79 0.52, 1.0 
Disabled  0.56 0.13, 0.94 
LTC 0.36 0.03, 0.69 
No 
Therapy 
Nondisabled 0.79 0.51, 1.0 
Disabled  0.65 0.22, 1.0 
LTC 0.36 0.03, 0.69 
Probabilities  
CSRT 
Nondisabled to Death 0.017 0.0, 0.27 
Nondisabled to LTC 0.01 0.0, 0.21 
Nondisabled to 
Disabled 
0.052 0.0, 0.44 
Disabled to Death 0.03 0.0, 0.36 
Disabled to LTC 0.05 0.0, 0.48 
Disabled to 
Nondisabled 
0.12 0.0, 0.61 
LTC to death 0.07 0.0, 0.57 
No 
Therapy 
Nondisabled to Death 0.017 0.0, 0.27 
Nondisabled to LTC 0.01 0.0, 0.21 
Nondisabled to 
Disabled 
0.18 
0.0, 0.90 
Disabled to Death 0.03 0.0, 0.36 
Disabled to LTC 0.05 0.0, 0.48 
Disabled to 
Nondisabled 
0.06 
0.0, 0.41 
LTC to death 0.07 0.0, 0.57 
*Ranges are 95% Confidence Intervals 
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Appendix 5: Parameter distributions in the Probabilistic Sensitivity Analysis 
Parameter   
Distribution 
Type 
Point 
Estimate 
Variation 
Cost 
CSRT 
Nondisabled Log Normal 
7.94 
6.67 
6.95 
SD of logs= 1.09 
SD of logs= 1.08 
SD of logs= 1.53 
Disabled  
Log Normal 8.78 
8.41 
7.1 
SD of logs= 0.95 
SD of logs= 0.99 
SD of logs= 1.7 
LTC Log Normal 9.62 SD of logs= 1.15 
No 
Therapy 
Nondisabled 
Log Normal 8.69 
8.32 
6.95 
SD of logs= 0.97 
SD of logs= 8.3 
SD of logs= 1.53 
Disabled  
Log Normal 8.38 
8.3 
7.1 
SD of logs= 1.45 
SD of logs= 1.44 
SD of logs= 1.7 
LTC Log Normal 9.62 SD of logs= 1.15 
Utilities 
CSRT 
Nondisabled Beta 0.79 α= 7.30 β= 1.50 
Disabled  Beta 0.56 α= 3.91 β= 2.10 
LTC Beta 0.36 α= 2.51 β= 4.46 
No 
Therapy 
Nondisabled Beta 0.786 α= 7.30 β= 1.50 
Disabled  Beta 0.65 α= 3.91 β= 2.11 
LTC Beta 0.36 α= 2.51 β= 4.46 
Transition 
Probabilities 
CSRT 
Nondisabled to 
Death 
Beta 
0.017 
α= 0.00001
  
β= 0.00052 
Nondisabled to 
LTC 
Beta 
0.01 
α= 0.00010
  
β= 0.00986 
Nondisabled to 
Disabled 
Beta 
0.052 
α= 0.01208
  
Β= 0.22032 
Disabled to 
Death 
Beta 
0.03 
α= 0.00025
  
β= 0.00839 
Disabled to LTC 
Beta 
0.05 
α= 0.00548
  
β= 0.09548 
Disabled to 
Nondisabled 
Beta 
0.12 
 
α= 0.02483 
 
 
β= 0.17652 
 
LTC to death Beta 0.07 α= 0.00237 β= 0.04122 
No 
Therapy 
Nondisabled to 
Death 
Beta 
0.017 
α= 0.00001
  
β= 0.00052 
Nondisabled to 
LTC 
Beta 
0.01 
α= 0.00010
  
β= 0.00986 
Nondisabled to 
Disabled 
Beta 
0.18 
α= 0.015831
  
β= 0.07131 
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Health Questionnaire 
 
 
English version for Canada 
 
Appendix 6: EQ-5D-5L 
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Under each heading, please tick the ONE box that best describes your health TODAY  
 
MOBILITY 
I have no problems in walking about      
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
 
SELF-CARE 
I have no problems washing or dressing myself     
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself     
I am unable to wash or dress myself       
 
USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities      
 
PAIN / DISCOMFORT 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
 
ANXIETY / DEPRESSION 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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We would like to know how good or bad your health is TODAY. 
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
The best health        
 you can imagine 
The worst health        
 you can imagine 
This scale is numbered from 0 to 100. 
100 means the best health you can imagine. 
0 means the worst health you can imagine. 
Mark an X on the scale to indicate how your  
health is TODAY. 
Now, please write the number you marked on the scale 
in the box below.  
 
 
YOUR HEALTH TODAY  = 
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Appendix 7: Stroke Impact Scale 
 
 
 
Stroke Impact Scale 
 
VERSION 3.0 
 
 
 
 
The purpose of this questionnaire is to evaluate how stroke 
has impacted your health and life. We want to know from 
YOUR POINT OF VIEW how stroke has affected you. 
We will ask you questions about impairments and 
disabilities caused by your stroke, as well as how stroke 
has affected your quality of life. Finally, we will ask you to 
rate how much you think you have recovered from your 
stroke. 
(*denotes question from SIS-16) 
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Stroke Impact Scale 
 
These questions are about the physical problems which may have occurred 
as a result of your stroke. 
 
1. In the past week, how would A lot of Quite a bit Some A little No 
you rate the strength of your.... strength of strength strength strength strength at 
     all 
a. Arm that was most affected by 5 4 3 2 1 
your stroke?      
b. Grip of your hand that was 5 4 3 2 1 
most affected by your stroke?      
c. Leg that was most affected by 5 4 3 2 1 
your stroke?      
d. Foot/ankle that was most 5 4 3 2 1 
affected by your stroke?      
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These questions are about your memory and thinking. 
 
2. In the past week, how difficult Not A little Somewhat Very Extremely 
 
was it for you to... 
difficult at difficult difficult difficult difficult 
 
all     
 
a. Remember things that people just 5 4 3 2 1 
 
told you?      
 
b. Remember things that happened the 5 4 3 2 1 
 
day before?      
 
c. Remember to do things (e.g. keep 5 4 3 2 1 
 
scheduled appointments or take      
 
medication)?      
 
d. Remember the day of the week? 5 4 3 2 1 
 
      
 
e. Concentrate? 5 4 3 2 1 
 
      
 
f. Think quickly? 5 4 3 2 1 
 
      
 
g. Solve everyday problems? 5 4 3 2 1 
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These questions are about how you feel, about changes in your mood 
and about your ability to control your emotions since your stroke. 
 
3. In the past week, how often did None of A little of Some of Most of All of the 
you... the time the time the time the time time 
a. Feel sad? 5 4 3 2 1 
      
b. Feel that there is nobody you are 5 4 3 2 1 
close to?      
c. Feel that you are a burden to others? 5 4 3 2 1 
      
d. Feel that you have nothing to look 5 4 3 2 1 
forward to?      
e. Blame yourself for mistakes that 5 4 3 2 1 
you made?      
f. Enjoy things as much as ever? 5 4 3 2 1 
      
g. Feel quite nervous? 5 4 3 2 1 
      
h. Feel that life is worth living? 5 4 3 2 1 
      
i. Smile and laugh at least once a day? 5 4 3 2 1 
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The following questions are about your ability to communicate with 
other people, as well as your ability to understand what you read 
and what you hear in a conversation. 
 
 
4. In the past week, how difficult Not A little Somewhat Very Extremely 
 
was it to... 
difficult at difficult difficult difficult difficult 
 
all     
 
a. Say the name of someone  who was 5 4 3 2 1 
 
in front of you?      
 
b. Understand what was being said to 5 4 3 2 1 
 
you in a conversation?      
 
c. Reply to questions? 5 4 3 2 1 
 
      
 
d. Correctly name objects? 5 4 3 2 1 
 
      
 
e. Participate in a conversation with a 5 4 3 2 1 
 
group of people?      
 
f. Have a conversation on the 5 4 3 2 1 
 
telephone?      
 
g. Call another person on the 5 4 3 2 1 
 
telephone, including selecting the      
 
correct phone number and dialing?      
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The following questions ask about activities you might do 
during a typical day. 
 
5. In the past 2 weeks, how difficult Not difficult A little Somewhat Very Could not 
 
was it to... 
at all difficult difficult difficult do at all 
 
     
 
a. Cut your food with a knife and fork? 5 4 3 2 1 
 
      
 
b. Dress the top part of your body?* 5 4 3 2 1 
 
      
 
c. Bathe yourself?* 5 4 3 2 1 
 
      
 
d. Clip your toenails? 5 4 3 2 1 
 
      
 
e. Get to the toilet on time?* 5 4 3 2 1 
 
      
 
f. Control your bladder (not have an 5 4 3 2 1 
 
accident)?*      
 
g. Control your bowels (not have an 5 4 3 2 1 
 
accident)?*      
 
h. Do light household tasks/chores 5 4 3 2 1 
 
(e.g. dust, make a bed, take out      
 
garbage, do the dishes)?      
 
i. Go shopping?* 5 4 3 2 1 
 
      
 
j. Do heavy household chores (e.g. 5 4 3 2 1 
 
vacuum, laundry or yard work)?*      
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The following questions are about your ability to be mobile, 
at home and in the community. 
6. In the past 2 weeks, how difficult Not A little Somewhat Very Could 
 
was it to... difficult difficult 
difficult 
difficult not do at 
 
 
 
 at all    all 
 
a. Stay sitting without losing your 5 4 3 2 1 
 
balance?*      
 
b. Stay standing without losing your 5 4 3 2 1 
 
balance?*      
 
c. Walk without losing your balance?* 5 4 3 2 1 
 
      
 
d. Move from a bed to a chair?* 5 4 3 2 1 
 
      
 
e. Walk one block?* 5 4 3 2 1 
 
      
 
f. Walk fast?* 5 4 3 2 1 
 
      
 
g. Climb one flight of stairs?* 5 4 3 2 1 
 
      
 
h. Climb several flights of stairs? 5 4 3 2 1 
 
      
 
i. Get in and out of a car?* 5 4 3 2 1 
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The following questions are about your ability to use your hand that 
was MOST AFFECTED by your stroke. 
 
7. In the past 2 weeks, how difficult Not A little Somewhat Very Could not 
 
was it to use your hand that was most difficult difficult 
difficult 
difficult do at all 
 
  
affected by your stroke to... 
at all     
 
      
a. Carry heavy objects (e.g. bag of 5 4 3 2 1 
 
groceries)?*      
 
b. Turn a doorknob? 5 4 3 2 1 
 
      
 
c. Open a can or jar? 5 4 3 2 1 
 
      
 
d. Tie a shoe lace? 5 4 3 2 1 
 
      
 
e. Pick up a dime? 5 4 3 2 1 
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The following questions are about how stroke has affected your ability to 
participate in the activities that you usually do, things that are meaningful to 
you and help you to find purpose in life. 
 
 
8. During the past 4 weeks, how None of A little of Some of Most of All of the 
much of the time have you been the time the time the time the time time 
limited in...      
a. Your work (paid, voluntary or other) 5 4 3 2 1 
      
b. Your social activities? 5 4 3 2 1 
      
c. Quiet recreation (crafts, reading)? 5 4 3 2 1 
      
d. Active recreation (sports, outings, 5 4 3 2 1 
travel)?      
e. Your role as a family member 5 4 3 2 1 
and/or friend?      
f. Your participation in spiritual or 5 4 3 2 1 
religious activities?      
g. Your ability to control your life as 5 4 3 2 1 
you wish?      
h. Your ability to help others? 5 4 3 2 1 
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9. Stroke Recovery  
 
On a scale of 0 to 100, with 100 representing full recovery and 0 representing 
no recovery, how much have you 
 
recovered from your stroke? 
 
 
100 Full Recovery 
 
__  
90 
 
__  
80 
 
__  
70 
 
__ 
______    60 
__  
50 
 
__  
40 
 
__  
30 
 
__  
20 
 
__  
10 
__ 
________ 0  
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